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ABSTRACT
In the last decades great breakthroughs have been achieved in the study of the
genomes, supplying us with the vast knowledge of the genes and a large number of
sequenced organisms. With the availability of genome information, the new systematic
studies have arisen. One of the most prominent areas is proteomics. Proteomics is a
discipline devoted to the study of the organism’s expressed protein content. Proteomics
studies are concerned with a wide range of problems. Some of the major proteomics
focuses upon the studies of protein expression patterns, the detection of protein-protein
interactions, protein quantitation, protein localization analysis, and characterization of
post-translational modifications. The emergence of proteomics shows great promise to
furthering our understanding of the cellular processes and mechanisms of life.
One of the main techniques used for high-throughput proteomic studies is mass
spectrometry. Capable of detecting masses of biological compounds in complex
mixtures, it is currently one of the most powerful methods for protein characterization.
New horizons are opening with the new developments of mass spectrometry
instrumentation, which can now be applied to a variety of proteomic problems. One of
the most popular applications of proteomics involves whole organism high-throughput
experiments. However, as new instrumentation is being developed, followed by the
design of new experiments, we find ourselves needing new computational algorithms to
interpret the results of the experiments. As the thresholds of the current technology are
being probed, the new algorithmic designs are beginning to emerge to meet the
challenges of the mass spectrometry data evaluation and interpretation.
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This dissertation is devoted to computational analysis of mass spectrometric data,
involving a combination of different topics and techniques to improve our understanding
of biological processes using high-throughput whole organism proteomic studies. It
consists of the development of new algorithms to improve the data interpretation of the
current tools, introducing a new algorithmic approach for post-translational modification
detection, and the characterization of a set of computational simulations for biological
agent detection in a complex organism background. These studies are designed to further
the capabilities of understanding the results of high-throughput mass spectrometric
experiments and their impact in the field of proteomics.
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Chapter 1
Introduction to Proteomic Analysis with Mass Spectrometry and General Mass
Spectrometry Data Analysis
Introduction
The proteome can be defined as the set of all expressed proteins in a cell, tissue or
organism. Proteomics is an emerging new discipline in the field of studying living
organisms being a direct continuation to the area of genomics; where as genomics is
concerned with the study of genetic codes of living organisms, proteomics is devoted to a
study of the organism’s expressed protein content. The study of genes is applied to
uncovering the secrets of life focusing on the genetic makeup, including the sequencing
and study of DNA patterns in nature. The Central Dogma of biology states: DNA is
transcribed into mRNA which in turn is translated to produce proteins. As opposed to the
relatively static study of a genome, proteomics is very dynamic, the protein content of a
living organism ever changing, starting with the programmed changes in the proteome
that deal with time points in life cycle and ending with the adapting the organism to
varying environmental conditions. The study of a proteome can address a wide range of
conditions such as discovering traces of disease, measuring body’s response to a
medication or detecting a particular protein compound in an organism. The area of
proteomics involves a wide range of studies dealing with proteins, including the study of
protein structure and function, post-translational modifications (PTMs), protein-protein
interactions, protein regulation and the study of complex protein networks.
A major area of proteomics deals with characterization of an organism’s
proteomic content. It is focused upon studying what proteins are present in an organism
1

under a particular condition. While the genome sequences supply the full DNA
information of an organism, proteomic studies measure the dynamics of an organism,
supplying a variety of information about an organism at a particular time. With
proteomics it became possible to measure the dynamics of an organism. In the last
decades great breakthroughs were achieved in the study of the genome, supplying us with
the vast knowledge of the genes and a massive amount of sequenced organisms. As the
genome information becomes more and more accessible, the need for further systems
level studies became clear; transcriptome studies and then proteomic studies became
prominent. Some of the major proteomic studies involve the studies of protein
expression patterns (protein cataloguing), detecting protein-protein interactions, protein
localization analysis, and analysis of post-translational modifications. One of the main
techniques used for high-throughput proteomic studies is mass spectrometry. It is
capable of detecting masses of biological compounds in complex mixtures and currently
one of the most powerful methods for protein detection and analysis.
Mass spectrometry
Mass spectrometry (MS) is one of the most indispensable tools for highthroughput proteomic analysis (Aebersold, 2003) due to its versatility and speed. It is a
fast and reliable tool capable of measuring masses of biological molecules in complex
mixtures (Pandley, 2000). Fundamentally, a mass spectrometer is an instrument
consisting of three parts: ionization source, ion analyzer and ion detector. The ionization
source is responsible for desorption and ionization of biological molecules into gas phase,
the ion analyzer separates them according to their mass to charge ratios (m/z) and ion
detector detects and multiplies the ion signal. The two ionization sources most frequently
2

used in proteomic analysis are electrospray (ESI) and matrix assisted laser desorption
ionization (MALDI) sources. The MALDI ionization technique involves transferring
biological molecules into gas phase from a solid matrix (Hillenkamp, 1991). This
ionization method produces low charge state molecules -- the ions measured by a mass
analyzer have in most cases single and double more rarely triple charges. ESI transfers
biological molecules directly from liquid matrix into gas phase (Fenn, 1989), producing
mainly multiply charged molecules. The masses of biological molecules reflect their
composition and are used for their detection and characterization.
In addition to measuring the masses of biological molecules, mass spectrometers
are also capable of producing sequencing information in a form of fragmentation pattern.
The fragmentation pattern of a peptide is produced by a process called tandem MS (or
MS/MS) (Hunt, 1981; Biemann, 1986). The tandem MS experiment involves the
following three steps: isolation of ions in a particular mass to charge ratio, fragmentation
of these ions, and the detection of the resulting fragment ions. The fragmentation is
performed by the process called collision induced dissociation (CID), which involves
colliding peptides of isolated m/z with inert gas, the collisions inducing breaks in the
peptide bonds, and resulting in a spectrum of mass to charge ratios for peptide fragments,
which are the function of the peptide sequence. Using the parent m/z of the peptide and
its fragmentation pattern, the identity of a biological molecule can be established through
a variety of database search algorithms.
The two major mass spectrometric techniques frequently used for protein analysis
are referred to as top down and bottom up methods. These two techniques approach
proteome analysis from the different angles as is illustrated in the figure 1.1.
3

Figure 1.1 Top down vs. bottom up mass spectrometric techniques. Top down MS
involves analyzing intact proteins, while the bottom up MS involves an extra step of
digesting the proteins into smaller peptides, measuring and analyzing the peptides and
then inferring the identities of the present proteins from the detected peptides.
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The top down approach involves analyzing intact proteins which are extracted from the
cell.

The bottom up approach analyzes peptides, the fragments of proteins resulting

from an enzymatic digestion, inferring the protein identities from the detected peptides.
These techniques are often complementary to each other: while the bottom up approach
produces more protein identifications, it does not supply the information about the state
of an intact protein (PTMs, N-terminal protein processing, splice site variants, and
amino-acid substitutions) and while top down experiment supplies the information about
intact proteins, it generally produces less protein identifications due to the limitations of
experimental technology and computational interpretations. Currently, the highthroughput proteomics tends towards bottom up techniques as the instrumental
technology is more robust and better developed.
Top down proteomics is a technique involving protein characterization at the
intact protein level by MS with possible following tandem MS analysis. Before proteins
are analyzed by MS, they are separated into smaller fractions. This separation process of
intact proteins is one of the most difficult challenges of current top down proteomics
technologies. One of the most popular techniques for intact protein separation is two
dimensional polyacrylamide gel electrophoresis (2-D PAGE gel), (O’Farell, 1975)
separating proteins by two criteria: isoelectric point in the first dimension and molecular
weight in the second dimension. While powerful, 2-D PAGE gel separation remains
difficult and slow process impeding the speed of intact protein analysis. Furthermore, the
extraction and subsequent MS analyses of intact proteins from 2-D PAGE gels is nearly
impossible. The MS analysis of intact proteins is generally performed using electrospray
ionization Fourier transform ion cyclotron resonance mass spectrometers (ES-FT-ICR5

MS) (Mortz, 1996; Kelleher, 1998). The instruments of this type have both high degree
of resolution, and mass accuracy up to 10-4 Da, both of which parameters play a
significant role in protein characterization. In addition, top down proteomic method can
also employ the tandem MS (or MS/MS analysis), providing a limited sequence
information for the measured protein. Top down analysis provides the information about
the mature proteins expressed in the organism, including the post-translational
modifications and amino acid substitutions. However, the interpretation of intact protein
analysis is frequently complicated by the absence of the exact corresponding protein
sequences in the database (PTMs, SNPs, etc.), while at experimental end separations with
liquid chromatography and measuring large proteins by MS can often be very difficult.
Top down mass spectrometry in general is not yet applied for high-throughput proteomic
studies. While other methodologies are introduced in the dissertation, the work is
focused upon the data interpretation for the bottom up “shotgun” proteomics introduced
below and unless otherwise stated all of the references to MS and data analysis
correspond to these experiments.
There are many avenues for bottom up proteomics which involve a multitude of
techniques. The two most popular of the bottom up techniques are “shotgun” bottom up,
(which will later be referred to simply as bottom up) and peptide mass fingerprint (PMF)
analysis. The main technique for high-throughput protein identification using tandem
mass spectrometry is called bottom up or “shotgun” approach. A typical complex
mixture bottom up experiment involves a protein mixture digestion with an enzyme
protease (such as trypsin, pepsin, glu-C, etc), a separation of the complex mixture into
smaller fractions by such techniques by gel separations (Hess, 1993; Gatlin, 1998) or
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liquid chromatography (McCormack, 1997; Martin, 2000; Shen, 2001) followed by MS
analysis. The bulk of bottom up proteomic analysis is performed by ES ionization
sources coupled with ion trap mass analyzers. This instrument is fast, reliable and
affordable however, it has a limited resolution of approximately 0.5 Da. The MS
analysis yields information about the mass to charge ratio of the examined peptide while
MS/MS analysis provides information about the peptide amino acid sequence.
Another popular method for characterizations of complex mixtures is peptide
mass fingerprinting (PMF), which is a different approach to bottom up experiment. Like
the previously described “shotgun” bottom up technique, PMF involves digesting the
proteins into peptides and measuring their masses with mass spectrometry. The key
differences between PMF and shotgun bottom up technique is that PMF involves protein
separation (generally 2-D PAGE) and that tandem MS experiment is not performed.
Peptide masses are generally analyzed with MALDI TOF instruments. The protein
identification is made based upon identifying it’s peptides by their masses, the reliability
of protein identification dependant on the detected sequence coverage and pattern of
detected peptide masses.
Fragmentation pattern
Tandem MS or MS/MS peptide/protein fragmentation creates a sequence
dependent fragmentation pattern. The peptides tend to fragment by breaking along
peptide backbone bonds, each break creating a pair of fragment ions (Figure 1.2). The
fragment ions retaining N-terminus of a peptide are referred to as ‘a’, ‘b’, ‘c’ ions, while
the ions containing C-terminus are referred to as ‘x’, ‘y’, ‘z’ ions (Roepstorff, 1984;
Biemann, 1988).
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Figure 1.2 Tandem MS fragments. The representation of possible backbone
fragmentations. The ions containing N-terminus are referred to as ‘a’, ‘b’, ‘c’ ions, while
the ions containing C-terminus are referred to as ‘x’, ‘y’, ‘z’ ions.
In the case of low energy CID fragmentation, the ‘b’ and ‘y’ ions are the major ions in
the spectrum, all of the other types of ions shown in the figure 1.2 can be present, but at a
significantly lower abundance. In theory, the number of ‘b’ and ‘y’ ions for each given
peptide is roughly equal to the number of the peptide bonds, if the number of amino acids
in the peptide is equal to N, then the peptide will have a maximum of N-1 ‘b’ and N-1 ‘y’
ions (Figure 1.3). Each ion appears in the tandem MS spectrum in a form of a peak with
an m/z and intensity. Intensity of a peak is related to the abundance of the ions of this
m/z (Figure 1.3).
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Figure 1.3 Sequence dependent fragmentation pattern produced by CID. The
horizontal axis is representing the m/z ratios of the fragment ions and vertical axis is
representing the intensities of the fragment ions. The major ions in the CID spectrum are
the ‘b’ and ‘y’ ions. As shown, there is no easy differentiation between the ‘b’ and ‘y’
series in the ion trap tandem MS spectrum.

As a result of CID fragmentation the expected outcome is a pair of ‘b’ and corresponding
‘y’ ions at each amino acid position, producing so called ion series. The m/z difference
between two consecutive ‘b’ (and ‘y’) ions of a single charge (equivalent to a single
amino acid mass) can be used to infer the identity of an amino acid between them as
shown in figure 1.3, from “Introduction to Proteomics” by Dan Liebler (Page 95, Figure
4). This property is extensively used by many of the peptide identification algorithms to
infer the sequence information from the tandem MS spectrum.
9

Mass spectrometry is used to detect and identify protein content of complex
biological mixtures. Each of the outlined approaches, top down, bottom up and PMF is
applied to the proteomic studies. The majority of high-throughput proteomic analysis, as
previously stated, is performed by the bottom up mass spectrometry. A significant
portion of bottom up analysis is performed with the use of ES ion trap instruments. The
instrumentation and procedures are well characterized and developed, making proteome
analysis a comparably simple and routine task. Bottom up mass spectrometry can be
used for protein detection in complex mixtures; however, the identity of a protein in
bottom up analysis must be inferred from its detected peptides. Since not all of the
peptides are generally analyzed and interpreted, only partial sequence coverage is
possible and the protein in the complete form is generally not detected. In some cases
bottom up MS can be used to detect post-translational modifications if they are present in
the detected peptides. However, the analysis of post-translational modifications using the
current data interpretation methods is not straightforward. Some of the major problems
with PTM detection are: a) difficulty with ionizing modified peptides, as modifications
frequently change peptide properties, b) modifications can cause complications in tandem
MS spectra such as reducing peptide fragmentation, c) there are no rigorous computer
algorithms for identification of modified peptides. Chapter 4 of this dissertation addresses
this very important and interesting task of high-throughput PTM detection by bottom up
mass spectrometry.
The top down approach is used to detect intact proteins as they appear in the
sample. As opposed to the bottom up technique, the entire protein is characterized by top
down mass spectrometry, including the possible post-translational modifications and
10

sequence mutations. As is explored in Chapter 5 of the dissertation, it can be applied to
detecting a particular protein or even an organism in a biological sample. In addition, top
down approach can be expected to be less computationally intensive as there is
significantly smaller number of intact proteins that can be measured with mass
spectrometry than the peptides. However, the top down approach is more difficult
experimentally, the difficulties laying in the protein separation, gas phase conversion and
performing MS/MS on intact proteins.
Mass spectrometric data analysis
While mass spectrometers produce meaningful information about masses of
biological molecules, computational data interpretation is necessary to discover the
identity of the measured biological molecules. In order to interpret mass spectrometric
data, a multitude of computation methods have been developed. There are three basic
approaches to bottom up MS data interpretation: database search algorithms, de novo
sequencing algorithms and hybrid algorithms. The database search algorithms are
currently the main tools for bottom up MS data interpretation, the de novo sequencing
and hybrid algorithms are relied upon in cases when the database is not available or the
database searches do not produce adequate results.
Database search algorithms
The most commonly used methods for bottom up mass spectrometry data
interpretation are the database searches. Database searches are robust, reliable, sensitive
and fast approaches for peptide identification. All of the database search algorithms have
an inherent similarity: they operate based on the sequence database generally specific to
the organism of interest. Database search algorithms rely on the comparison between the
11

theoretical fragmentation patterns of peptides derived from the database and the
experimental peptide fragmentation pattern. Such tools produce a list of possible peptide
assignments and theoretical fragmentation patterns for each experimentally measured
tandem MS fragmentation pattern based on m/z of the parent peptide. The theoretical
fragmentation patterns are scored against the experimental tandem spectrum and the
theoretical peptide that displays the highest similarity to the experimental measurements
is accepted as the best candidate. There are basic two assumptions that database search
algorithms make that must be met in order for the identification to be successful. The
first assumption is that the peptide represented by the tandem MS spectrum is present in
the database in exactly the same form as it is in the sample. The second assumption is
that if the peptide which gave rise to the tandem MS spectrum has been found in the
database, its theoretical spectrum is more similar to the tandem MS spectrum than that of
any other peptide in the database. There is a multitude of database search algorithms for
MS data interpretation such as MASCOT (Perkins, 1999), SEQUEST (Eng, 1994),
DBDigger (Tabb, 2005), Sonar (Field, 2002), ProteinProspector (Clauser, 1999), and
OMSSA (Geer, 2004). While the software design of the algorithms varies to improve
speed and flexibility, the main differences in performance are dependent on two factors:
the selection of candidate peptides and the scoring scheme used for spectral comparison.
The selection of candidate peptides for database search algorithms is generally based on
the mass window of the measured precursor peptide. The scoring schemes can vary
between spectral comparisons, which take into account the similarity of two spectra, and
complex probabilistic approaches, which attempt to assess the probability of match by
incorporating the whole database into the comparison. One of the oldest and most
12

established database search program is SEQUEST (Eng, 1994), developed in 1994. It
involves an adaptation of a cross correlation scoring scheme for experimental and
theoretical spectra comparison. While sensitive, the X-correlation scorer does not
provide information on the identification probability. Chapter 2 of this dissertation
addresses the need for a reliability scheme for SEQUEST scoring for statistically sound
peptide and protein identification.
De Novo algorithms
De Novo algorithms have always been the “silver bullet” of mass spectrometry
data interpretation, in theory abolishing the need for databases by deriving sequence
information directly from the tandem MS spectra. When sequence databases are not
available or there is an inconsistency between the database and the protein of interest
people often resort to “sequencing by hand”. The term “sequencing” in application to
tandem MS data means reading sequence off the spectrum and in the majority of cases
produces either a partial (several amino acids long) or a full sequence of the peptide in
question. De Novo is the name that people apply to the algorithms that use tandem MS
spectrum to derive the full length sequence (or it’s majority), using the same concepts as
do humans while performing “sequencing” by hand. Unfortunately at this time, this
promising and inspiring approach does not demonstrate any degree of robustness and
sensitivity that has been demonstrated by generally much more simplistic database search
algorithms for the low resolution ion trap data and while it is promising technique for
higher resolution instrumentation such instruments are not currently used for shotgun
proteomic experiments. In addition, de novo approaches are generally very slow, taking
significantly more time than the database search algorithms, while producing a
13

significantly greater number of false positives. The difference between de novo and
database search approaches is such that their performance is considered not comparable.
De novo approaches are more likely to be used when a tandem spectrum of a good quality
cannot be identified by a database search, and then the likelihood of success is often
small. Similarly to the database search, de novo methods generally provide an answer,
however, even though a partial sequence might be found correctly; to find the fully
correct sequence or even predict which part of the sequence is correct is very hard. Some
of examples of well known de novo programs are PEAKs (Ma, 2003), Lutefisk (Taylor,
2001), and Sherenga (Dancik, 1999).
Hybrid approach
Hybrid data interpretation is a more flexible method than the database search. It
is based on performing the database search based on short amino acid tag (peptide tag),
rather than on the mass of the peptide which allows for a better PTM search as PTMs
affect the mass of measured peptide, preventing the mass filtering from finding correct
candidate peptide from the database. There are several approaches to finding a peptide
tag, for example, Mann and Wilm in 1994 introduced a reasonably successful Peptide
Sequence Tag approach (Mann, 1994). The other representatives of the hybrid approach
are GutenTag, developed by David Tabb (Tabb, 2003), and one of the most recent hybrid
approach MultiTag (Sunyaev, 2003). The basic flexible hybrid approach is based on
finding a continuous short amino acid sequence tag from a tandem MS, searching the
database based on the tag and masses flanking the tag, scoring the database peptide
sequences against the original tandem MS, and reporting the best fitting candidate
sequence. This type of approach might show an improvement over simple peptide mass
14

database search, being less sensitive to one or two amino acid substitutions in the peptide
sequence, since it is possible to search the database by degenerative tags and either or
none of the flanking masses. However, it is difficult to rigorously assess the reliability of
an amino acid tag. In addition, many of the short amino acid tags match the database,
the possibility of degenerate tag and flanking masses creates a large number of false
positives as well as false negatives.
Overview of the dissertation
The goal of this dissertation is to address some of the problems in mass
spectrometric data interpretation. As the field of mass spectrometry expands, the
experiments are becoming more complex and demand better data interpretation. The
majority of algorithmic tools currently widely used for the data interpretation are a few
years old. While being well tested and robust, they often lack the flexibility and accuracy
required to deal with the increasing demands of the field. It can therefore be expected
that with this rising demand new data interpretation tools will be continuously developed
in the future years. This dissertation addresses a few of the concerns of mass
spectrometric data interpretation for bottom up shotgun high-throughput proteomics.
Some of the common problems in bottom up MS data involve assigning reliability to the
peptides and proteins identified by SEQUEST, one of the accepted database search
algorithms up to date; determination of peptide mass based on mass to charge ratio (m/z
deconvolution); and the detection of post-translational modifications. These three
problems of MS data interpretation comprise three chapters of this dissertation. Mass
spectrometry is becoming a promising tool for organism detection based on its proteomic
content which can be an invaluable resource for detection of biological agents in the
15

environment. The fifth chapter of the dissertation presents a series of computer
simulations made to probe the capabilities of mass spectrometry as biological agent
detector.
The second chapter of the dissertation is focused on designing a new scheme to
assess the reliability of peptide and protein detection made by SEQUEST. SEQUEST is
one of the most popular database search tools used for bottom up MS data interpretation,
which currently employs simple filtering procedures for peptide and protein detection
without assessing the likelihood of the correct identification. The results of SEQUEST
data interpretation are sorted and ranked by its scoring scheme and the peptide
identification receiving the highest score is considered to be the correct answer. The
people using the software are then free to accept or reject any of the identifications made
based on the score cutoffs accepted in their laboratory. However, the score is frequently
influenced by such factors as peptide length, peptide charge, spectral quality and even
digest procedures. The lack of accepted reliability scheme causes difficulties in accurate
peptide detection as well as making it difficult to assess the likelihood associated with
protein identification. The presented work suggests a new neural network based
approach to assess the reliability of peptide identifications by SEQUEST and, using the
new strategy, proposes a scheme for reliability of protein identifications.
A new algorithmic approach for charge state deconvolution for low resolution
mass spectrometry is presented in the third chapter of the dissertation. While other
methodologies are emerging, the tools employed as driving force of proteomic efforts
today are electrospray ion-trap instruments. While they are robust, sensitive, fast and
easily coupled to liquid chromatography separations, they are also low-resolution
16

techniques. Electrospray ionization technique produces multiple charged peptides and
MS analyzers measure m/z ratio. The low resolution of ES ion-trap instruments does not
allow to definitively recognize the charge state of the peptide ion measured by MS which
leads to an ambiguity in the peptide mass. The presented work explores the
fragmentation pattern for charge specific characteristics and employs a trained artificial
neural network to differentiate between the multiply charged spectra. This methodology
both reduces the number of spectra by eradicating precursor mass ambiguities and
improves the performance of the analysis by potentially decreasing the number of
incorrect identifications. Additionally, in the chapter, a new performance evaluation
method is introduced and used to evaluate the presented charge state determination
method.
In the fourth chapter of the dissertation, an organism-specific detection of posttranslational modifications by bottom up proteomic analysis is addressed. A new PTM
driven database search algorithm is introduced and tested on several growth conditions of
the metabolically versatile prokaryotic organism Rhodopseudomonas palustris. The
detection of post-translational modifications is an extremely difficult and important
problem. Mass spectrometry is uniquely qualified for high throughput protein
modification detection due to the changes in the protein mass. However, interpretation of
mass spectrometric data for post-translationally modified proteins is especially difficult
due to the amount of false identifications and explosive database sizes. A detection of
biologically sound post-translational modifications in an organism of interest was
approached by building an organism specific post-translational modifications annotated
homology based database and developing a set of criteria for a reliable identification.
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The database was built to include only the experimentally observed post-translational
modifications, greatly reducing the number of false positive identifications, database size
and time of analysis. The method for reliable detection of post-translational
modifications included a combination of a database search approach combined with a set
of rules increasing the reliability of detection and reducing the number of incorrect
identifications.
The fifth chapter of the dissertation is devoted to a set of computational
simulations for biological agent detection via mass spectrometry. With the use of mass
spectrometers, proteins present in complex mixtures can be analyzed and identified. This
concept can be extended to proteome based organism detection in a complex multiorganism mixture. Organism detection in a complex background can be useful in
detecting harmful organisms in the environment, water supplies and food sources and is
already considered for use in the detection of biological weapons. However, there are
many limitations to the current technology which must be overcome before the
instruments and data analysis algorithms are capable of undertaking high-throughput
organism detection. The simulations presented in Chapter 5 of this dissertation are
designed to examine the pros and cons of top down and bottom up MS detection
techniques and explore the instrumental parameters needed for detection of an organism
in a complex environmental sample.
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Chapter 2
A Computational Method for Assessing Peptide-Identification Reliability in
Tandem Mass Spectrometry Analysis with SEQUEST
Some of the text presented below has been published as Razumovskaya J., Olman V., Xu
D., Uberbacher E., Nathan Verberkmoes, Hettich R.L., Xu Y., Proteomics, 2004., Apr;
4(4):961-9.
Introduction
One of the most important goals in systems biology is to identify and characterize
the protein composition of cells as a function of conditions (Pandley, 2000). Mass
spectrometry has become a fast and reliable tool for determining the protein composition
of complex mixtures by measuring mass to charge ratios of proteins and peptides in
mixtures. A very popular technique for whole proteome characterization is bottom up
shotgun mass spectrometry.
Many tools have been developed for high-throughput peptide identifications for
bottom up shotgun mass spectrometry such as SEQUEST (Eng, 1994; Yates, 1995;
Yates, 1995*), MASCOT (Perkins, 1999) SONAR (Field, 2002) and others. Most of the
current applications are database search based: they rely on the comparison between
theoretical peptides derived from the database and experimental mass spectrometric
tandem spectra. The database theoretical peptides are scored against the experimental
tandem spectrum and the theoretical peptide that displays the highest similarity to a
corresponding experimental spectrum, according to accepted scoring scheme is
considered to be the best hit. SEQUEST is one of earliest developed and still a very
popular tool for peptide identification. From a tandem mass spectrometry experiment,
SEQUEST produces a list of possible peptide assignments in a protein mixture. For each
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candidate peptide, it assigns scores, including the X-correlation score, the final score
produced by SEQUEST, the charge state of the peptide and several others. The peptide
identification process takes place after SEQUEST produces peptide identifications and
involves a number of filtering steps based on the aforementioned scores. The two main
SEQUEST scores used for filtering are the X-correlation score and the number of
charges, though other scores can also be used. SEQUEST peptide hits are generally
ranked based on their X-correlation scores. One problem with the current SEQUEST
scoring scheme is that a SEQUEST score, say the X-correlation score = 2.5, may have
different meanings for different peptides with different lengths and charges, making it
difficult to interpret the SEQUEST identification results automatically. For some
annotated data sets (Keller, 2002), the distributions of X-correlation score along with the
charge states for the correct and incorrect hits do not have a clear separation.
A possible solution to the problem is to develop a scheme to estimate the
identification reliability for each SEQUEST hit, based on the SEQUEST scores. The
preliminary analyses of SEQUEST search results have suggested that it is possible to
achieve this by combining different SEQUEST scores.
There have been several attempts to separate correct SEQUEST assignments from
the incorrect ones (Yates, 1995). Recently, a statistical approach was reported to assign
reliabilities to peptide hits using a database consisting of 18 protein sequences -- these are
Drosophila proteins with possible human contaminants (Keller, 2002). The score
distributions for the correct and incorrect peptide assignments were used to create a
statistical model from which the probabilities of correct and incorrect assignments were
derived. This method was designed to filter out a large number of database search results
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with predictable false identification error rates. The probability distributions were
represented as normal and gamma distributions. This approach relies on fitting the
experimental data to these distributions without theoretical justification for the
phenomena which might not be reflected under different conditions. The method is
focused on a specific experimental design involving tryptic digest coupled with nonspecific digest SEQUEST data analysis, as one of the given parameters is NTT (number
of tryptic termini), which although might insure an improvement under this specific
experiment, is not applicable to other type of experiments.
In another recent study, a support vector machine (SVM) technique was applied
to separate correct SEQUEST identifications from the incorrect ones (Keller, 2002).
SVM is a binary classifier that learns to distinguish between correctly and incorrectly
identified peptides by using a vector of parameters describing each peptide identification.
This method improved upon the simple cutoff approach, currently used in SEQUEST, for
separating the correct and the incorrect peptide identifications, but it does not provide an
estimate of the reliability of each identified peptide.
In this chapter, a new scheme is described for assessing reliabilities of peptide
identifications made by SEQUEST. In the scheme, peptide scores are normalized and
their probabilities to be correct are statistically estimated. These peptides and assigned
probabilities are then used to provide a statistical assessment for protein identification.
This method is based on a combined application of a statistical decision-making
procedure and a neural network. The training of the neural network was accomplished
using a set of tryptic peptides from known proteins measured by mass spectrometry and
analyzed by SEQUEST. The SEQUEST results were separated into correct and incorrect
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identifications by careful manual analysis. Once trained, the neural network provides a
score between 0.0-1.0 for each peptide, reflecting the probability of a peptide to be the
correct identification.
One advantage of this approach is that it provides improved resolution of
assignments for peptides that SEQUEST scores in the "gray area". In this current
approach, each peptide hit has a particular level of confidence associated with its
SEQUEST score. This confidence value can then be used in conjunction with other
parameters to assign a reliability estimate for protein identification, which typically
corresponds to a number of peptides identified in a protein.
The trained neural network was evaluated on two sets of data, one representing a
relatively simple mixture of proteins, and one complex mixture. The evaluation was
based on two accepted parameters often used in method comparisons: sensitivity and
specificity. Sensitivity is the ratio between the number of correctly predicted hits and the
number of all correct peptide assignments, while the specificity is defined as the ratio
between the number of correctly predicted hits and the total number of hits. The formula
for sensitivity is described as
TP
TP + FN

[1]

and specificity is
TP
TP + FP

[2]

where TP denotes the number of true positives, FN denotes the number of false negatives,
and FP, the number of false positives. The test results showed a significant improvement
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in both the identification sensitivity and specificity for peptides by this method, compared
to the standard SEQUEST filtering procedure. Based on this peptide-identification neural
network, we have developed a statistical model for protein identification, through
combining peptide-identification reliability estimates. To evaluate this approach,
comparisons were performed on our statistical model and one current filtering procedure
of SEQUEST, called DTASelect (Tabb, 2002). This method yielded a significantly
larger set of protein identifications than the filtered DTASelect, showing 20%
improvement in sensitivity over the filtered DTASelect in the first 70 ranked protein
identifications (with the same specificity). These results demonstrate that the combined
neural network method and statistical model is more sensitive than filtered DTASelect
while maintaining the same specificity, and more specific than the results of DTASelect
without application of filters (later to be referred to as unfiltered DTASelect), which was
applied for higher sensitivity of protein identifications, while maintaining the same
sensitivity.
Materials and Methods
Data set for neural network training
An 18 protein sequence dataset was used as the training data set for the neural
network. This set was obtained from a mixture analyzed by the Institute for Systems
Biology (ISB) (Keller, 2002*). The 18 purified proteins, placed in the mixture and
digested with trypsin, were: bovine β-casein, bovine carbonic anhydrase, bovine
cytochrome c, bovine β-lactoglobulin, bovine α-lactalbumin, bovine serum albumin,
chick ovalbumin, bovine transferrin, rabbit GAPDH, rabbit phosphorylase b, E. coli β-
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galactosidase, bovine γ-actin, bovine catalase, rabbit myosin, E. coli alkaline
phosphatase, horse myoglobin, B. lichenformis α-amylase, and S. cerevisiae
phosphomannose isomerase. Keller et al. performed an analysis, using SEQUEST, to
identify the peptides. The search was performed against the human protein database plus
these eighteen protein sequences. The assignments of spectra to peptides were confirmed
through thorough manual examination. Keller et al. (Keller, 2002*) did peptide
assignment in the following way: if a peptide did not belong to the set of expected
proteins, its assignment was considered incorrect; otherwise they were manually
examined before being considered as correct. Detailed manual analysis also revealed that
this set contains additional proteins from human contamination. Hence the set actually
consists of 29 proteins.
The final list of correct assignments consists of 2,784 peptides, confidently
identified in the mixture; and the list of incorrect assignments contains 34,287 peptide
hits by SEQUEST (Table 2.1). The incorrect assignments could be due to limitations of
SEQUEST interpretation, or to the presence of bad spectra. These data were used to train
our neural network. Using this dataset, the sensitivity using a “normal” X-correlation
cutoff (1.8 for charge state 1, 2.5 for charge state 2, and 3.5 for charge state 3) was found
to be 66%, with a specificity of 89%, while the sensitivity using a “minimal” cutoff (1.5
for charge state 1, 2.3 for charge state 2, and 3 for charge state 3) was found to be 75%,
with a specificity of 84%, in comparison to the neural network approach, which at
specificity of 89% has sensitivity of 89%.
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Table 2.1. Peptide assignment results for the ISB protein mixture.
Charge state

Correct

Incorrect

+1

125

379

+2

1649

16856

+3

1010

17052

Assignments used in the neural network training. The first column indicates the charge
state. The second column shows the number of the correct peptide assignments found by
SEQUEST through database search and confirmed by manual interpretation. The third
column represents the incorrect peptide assignments.

Neural network selection and training
The first goal with neural network application is to identify which peptideassignments by SEQUEST are correct and which ones are incorrect, through applications
of other parameters in addition to the X-correlation scores and the charge states.
The preliminary studies have suggested the following six parameters should be useful in
helping to achieve this goal: the SEQUEST X-correlation score (measure of likelihood
of an experimental spectrum to be a representation of a theoretical peptide), peptide
charge state (1, 2 or 3), ∆Cn (∆Cn - the difference between X-correlations of the top and
the second top hits in the SEQUEST output for a particular experimental spectrum),
SpRank (rank of the peptide in the preliminary scoring), ion coverage (percent of
matched peaks), and the length of the peptide. Several other scores were also evaluated
in the preliminary studies, including dM (mass difference between theoretical and
experimental parent ions) and Sp (SEQUEST preliminary score). However, it was found
that these do not improve the performance of our neural networks. Each of the training
data (2784 correct ones and 34287 incorrect ones) has six parameters associated with it
and a 0/1 (for “incorrect” and “correct”, respectively) label as the desired output value.
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70% of the data points from this data set were randomly selected as the training data and
the remaining 30% of the data as the testing set. The architecture of our neural network
has six input nodes corresponding to the selected input parameters, one hidden layer, and
one output node corresponding to the result of the neural net. Nodes of adjacent layers
are fully connected. Throughout the training process various neural network
architectures with different numbers of hidden nodes were evaluated.
A SNNS 4.2 (Stuttgart Neural Network Simulator) was used to train a neural
network to distinguish correct from incorrect peptide identifications. We used the backpropagation learning algorithm to train the connection weights. Performance results are
saved every 60 cycles throughout the training process. The training stops when no
improvement in the error rate could be achieved. Each of the resulting nets was then
tested for performance and the best was selected based on resulting sensitivity and
specificity. Neural network testing was performed using a jackknife approach where 30%
of the ISB data was held out for testing, while the rest was used for training. The
resulting neural network has a hidden layer with four hidden nodes. The neural network
output ranges from 0.0 to 1.0, where the output represents the network’s estimate of
assignment correctness. Each result of SEQUEST, its associated neural network score,
and its a priori classification can be used to generate histograms of the network’s
performance. An example histogram is shown in the figure 2.1.
Additional dataset for testing
A mixture of eight proteins was prepared as an additional test set: bovine hemoglobin
alpha chain (2mg), bovine hemoglobin beta chain (2mg), bovine carbonic
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Figure 2.1 Histogram of correct and incorrect peptide assignments made by neural network. The majority of incorrect
peptide assignments are at a range of 0-0.3 while the majority of correct peptide assignments have scores that range between 0.751.0. This histogram can be used to estimate the probability that a peptide with a given neural network score is correctly assigned.
The neural network output ranges from 0.0 to 1.0, where the output represents the network's estimate that each assignment is
correct. Each result of SEQUEST, its associated neural network score, and its a priori classification can be used to generate
histograms of the network's performance.
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anhydrase (2mg), horse myoglobin (1mg), bovine albumin (5mg), yeast alcohol
dehydrogenase chain I (3mg), yeast alcohol dehydrogenase chain II (3mg), and chicken
lysozyme (1mg). In order to denature the protein mixture, it was dissolved in 1ml of 6M
guanidine and 5mM DTT and heated at 60C for 1hour. Then 2ml of solution was diluted
to 10ml in Tris buffer and digested overnight with 1:50 aliquot of trypsin (60ug of
trypsin). The sample was treated with 10mM DTT for 1 hr at 60C, desalted with a
SepPak, completely dried, re-dissolved in 1ml of HPLC Buffer A and filtered resulting in
sample concentration of ~2mg/ml. This sample was then analyzed with ion trap
instruments (Thermo Finnigan LCQ-Deca). The sample was separated into three equal
parts: Sample I was analyzed using LC-MS/MS with a 30ul injection and the short LCMS
run. Sample II was concentrated to 10mg/ml and run with a 50ul injection with long LCMS run. Sample III was concentrated to 10mg/ml and run with 50ul injection with short
LC-MS run. The three samples were created in order to check the performances with
different concentration related detection levels.
The trained neural network was tested on the mass spectrometry data collected
under different conditions as defined in Samples I, II and III, respectively. In order to
assign peptides a Shewanella database was used in addition with the eight proteins
present in the mixture. The Shewanella database was selected for this task as there were
little sequence similarity between the organism’s proteins and the proteins present in the
sample. Thus, it was considered to be a good background for SEQUEST search.
SEQUEST (TurboSEQUEST v. 27) was used to search the database, using the default
parameters. 2980 assignments were made for Sample I; 2163 assignments for Sample II;
and 1186 assignments for Sample III. All the peptides identified by SEQUEST as
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belonging to the eight proteins present in the protein mixture were considered correct.
Peptides that correspond to both Shewanella proteins and the proteins from the test
mixture were taken out of the analysis. Remaining peptides attributed to proteins coming
from Shewanella were, therefore, considered to be incorrectly assigned. Results for
SEQUEST on this dataset are summarized in Table 2.2.
Probability model for peptide identification
Using the result of neural network training, P, the conditional probability of true
peptide identification given neural network score can be estimated using Bayesian
formula as follows. A probability of a peptide being correctly assigned, given a particular
neural network Score, is the ratio of the previously observed number of correct peptide
identifications with that given Score to the total number of peptides with that Score.
Formally, let P(C | Score) and P(I | Score) as the probabilities for a assignment to be
correct (C) and incorrect (I), respectively. P is estimated as P(C | Score) as frequency(C ,
Score)/frequency(Score), where frequency(E) is a frequency of event E from histogram
of neural network scores. Similarly, we estimate P(I | Score) as frequency(I ,
Score)/frequency(Score).
Protein identification
The above discussion is about identification of a peptide. Identification of a protein, from
the mass spectrometry data, is based on the identification of peptides that come from the
protein. In order to quantify the accuracy of protein assignment we have assessed the
likelihood of a false protein to be identified by chance. For estimating the reliability of
proteins in the mixture, the identified peptides are treated as independent observations (of
a potential protein) within the mixture. Due to the assumption of peptide
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Table 2.2 Peak assignment results for Sample I, Sample II and Sample III made by
SEQUEST.
Sample set

Correct

Incorrect

Sample I

487

2493

Sample II

345

1818

Sample III

245

941

The first column indicates the analyzed sample. The second column shows the correct
peptide assignments made by SEQUEST. The third column represents the incorrect
peptide assignments made by SEQUEST.
assignment independence, the probability of a false protein assignment can be calculated
by combining the probabilities of incorrect identification of its peptides as follows: Let
peptides a1, a 2...an be a complete set of peptides that belong to protein A (resulted from
the mixture analysis), the probability for ai to be a true hit is defined as pi, and mi is a
number of proteins that were found to contain peptide ai. Then the probability that
protein A is not in the mixture is estimated by value:
PScore =

1

∏ (1 − m

pi | ai ∈ A)

[3]

i

The result shows the likelihood of a protein being identified by chance, given the
collection of peptides that belong to the protein. The smaller this PScore, the less is the
chance that the protein identification occurred by chance and therefore, greater the
certainty that the protein is actually present in the mixture. Another method that utilizes a
similar protein reliability model is described by MacCoss et al (MacCoss, 2002),
however, with a very different peptide probability estimation (further discussed in Results
section).
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In this method, if multiple peptide assignments in the mixture correspond to the
same protein, the likelihood that that protein is present in the mixture increases. The
difference between this method and simple addition of number of peptides per protein, as
it has been done by DTASelect (where every accepted peptide contributes the same
amount) which also uses SEQUEST’s peptide identifications is that the contribution of
peptides to the final protein likelihood is based on their probability of correct
identification. In the current scheme, unreliable peptide hits contribute less than reliable
ones, but as the number of hits per protein increases, so does the likelihood of its
presence in the mixture. In addition to the assumption of independence of peptide
observations, it is assumed that non-unique peptides have equal chance to be produced by
any parent protein.
Results and Discussion
Peptide identification

We present the peptide identification results on the two test sets: the ISB set and
our own eight protein set, and compare these results with the simple SEQUEST
identification results, using both the normal and minimal cutoffs. We also provide a
performance comparison between our program and PepProphet, a software program
written by Keller et al. To facilitate the comparison, the identification sensitivity and
specificity were calculated for each range of the neural network score, between 0.0 and
1.0 with a 0.01 increment. The sensitivity and specificity of the SEQUEST normal and
minimal cutoffs were calculated. The comparisons between the neural network results,
the cutoffs and PepProphet are presented in figures 2.2 and 2.3. Figure 2.2 shows the plot
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Figure 2.2 Specificity vs. specificity for ISB dataset. Prediction specificity vs. sensitivity on the ISB test set for different
neural network scores, as compared to PepProphet results and to the SEQUEST predictions using both normal and minimal
cutoffs through DTASelect.
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Figure 2.3 Specificity vs. sensitivity of eight-protein dataset. Prediction specificity vs. sensitivity on the eight-protein set for
different neural network scores, as compared to PepProphet results and to the SEQUEST predictions using both normal and
minimal cutoffs through DTASelect.

33

of sensitivity and specificity for different values of the neural network score, as well as
for the minimal and normal cutoffs for the ISB test set and the results of PepProphet.
Here, the neural network significantly outperforms the SEQUEST cutoff method for both
the normal and minimal cutoffs. For example, at the 89% specificity, the SEQUEST
normal cutoff achieves a sensitivity level at 66% compared to 89% by our method. The
performances of the neural network and PepProphet are shown to be relatively similar
though neural network consistently outperforms PepProphet throughout the sensitivityspecificity plot.
Figure 2.3 shows the sensitivity versus specificity plot for different values of our
neural network score on the eight protein test set. Note that SEQUEST’s cutoff
performance is much better on the second set than on the first one because the first
dataset is more complex than the second, in terms of peptide compositions and spectral
quality. In addition, the first database for peptide searching is significantly larger than
the second one. The performance for our neural network and PepProphet, however,
appears to be somewhat lower in sensitivity on the eight protein set. The explanation for
this lies in the definition of correct hits for the eight protein set. All the peptides that
were assigned to the expected proteins were considered to be correct, even though the
assignment could happen by chance (with X correlation score sometimes less than 0.8).
These random hits were considered incorrect by all the methods and thus, their sensitivity
was penalized. The manually validated ISB set, however, does not contain any random
hits and therefore, the sensitivity of all the methods is higher. The performance of
PepProphet on the eight protein data set is very similar to the performance of the neural
network (neural network performs better than PepProphet in sensitivity except in the
34

specificity range greater than 92%). The similar level of performance on both sets, by
our neural network, indicates that our method is robust. While our neural network
approach improves on the prediction performance compare to SEQUEST’s cutoffs, a key
advantage of using this approach lies in its ability to provide probability assignments for
peptide identification and the potential to combine these for protein identification
reliability estimation.
Protein identification

SEQUEST generally provides a list of top ten hits for each experimental spectrum
that it assigns. It is a general practice to take the top hit as the correct assignment,
discarding the other nine. However, many people use the difference between the top
ranked hit (will be referred to as X-correlation(1)), and the second ranked hit (Xcorrelation(2), the number in parenthesis ranges from 1 to 10, indicating the number of
rank) to assess the goodness of the identification in the first hit (∆Cn). If there is no
significant difference between X-correlation(1) and X-correlation(2), the first hit’s
reliability is undermined. However, many researchers are still concerned with the
possibility of the second or even the third hit being correct rather than the first one. It is
difficult to assess statistics when SEQUEST identification with the first hit was incorrect,
but the second (or lower) hit was correct, since it involves ten times the manual effort
than that required for just the first hit. The ISB test set used in this paper for neural
network training does not contain any correct hits that are not ranked one. Thus, it was
not possible to train a neural net with the consideration of rank in the identification as a
parameter. We attempted to use the information from all ten SEQUEST identification
hits for protein reliability assignment. It was done with the use of the neural network
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(previously described) and without any consideration as to the rank of the peptide hit in
the SEQUEST identification (each peptide hit, regardless of rank, was treated equally).
For example, it is possible to have a peptide for which X-correlation(1) is lower than the
X correlation(2-10) of another peptide. This treatment of ranks is, of course, naive.
However, we decided to attempt this approach, which we call Neural Network 2, which
relies on hits with X-correlation(1-10) rather than Neural Network 1, which only relies on
hits with X-correlation(1). Thus, in Neural Network 2, the overall number of peptides
assigned to proteins is roughly ten times higher than in Neural Network 1. It was
hypothesized that even though the number of random hits in Neural Network 2 will be
increased, the number of correct hits will contribute more, achieving a greater separation
between signal and noise in protein identification.
To evaluate our method for estimating the reliability of protein
assignments, we compared the following four approaches: (1) protein assignment based
on the neural network scores for the top hit only (Neural Network 1), (2) protein
assignment based on the neural network output for the 10 top hits (Neural Network 2), (3)
DTASelect with the normal filter in SEQUEST, and (4) DTASelect without filters. On
the eight protein test set (the simpler one), both Neural Network 1 and Neural Network 2,
as well as DTASelect using the normal cutoff, identified all eight proteins as their top 8
predictions. Results of Neural Network 1and Neural Network 2 are shown in Table 2.3
and Table 2.4 respectively. A Pscore (Table 2.3, Table 2.4) is computed by combining
the probabilities of a protein’s peptides being incorrectly identified. The value, therefore,
represents the likelihood that the protein in the sample has been identified by chance.
Thus, the lower is Pscore, the higher the reliability of protein identification.
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Table 2.3 Performance of Neural Network 1 on the 8-protein dataset.
Rank PScore

#peptide

Protein Name

Hits
1

1.45417902267382e-145

150

gi|2190337|gnl|PID|e321614

2

3.16526496278431e-119

105

gi|2506462|sp|P02188|MYG_HORSE

3

1.15508933747051e-109

120

gi|1168350|sp|P00330|ADH1_YEAST

4

8.23525223578428e-63

53

gi|122361|sp|P01966|HBA_BOVIN

5

1.86784851604797e-61

58

gi|122572|sp|P02070|HBB_BOVIN

6

3.24834848406027e-38

40

sp|P00698|LYC_CHICK

7

5.91934606492622e-33

40

gi|115453|sp|P00921|CAH2_BOVIN

8

0.000420000000000001

6

gi|113380|sp|P00331|ADH2_YEAST

9

0.2288

5

Contig7971.revised.gene2331.protein

10

0.33

3

Contig7971.revised.gene1007.protein

The first 8 proteins are correctly identified with given probabilities in both neural net
results. Proteins with ranks 9 and 10 are not present in the sample and identified
incorrectly. In Neural Network 1 the difference in probabilities between protein with
rank 8 (correct) and protein with rank 9 (incorrect) is on the order of 1 order of
magnitude.
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Table 2.4 Performance of Neural Network 2 on the 8-protein dataset.
Rank PScore

#peptide

Protein Name

hits
1

3.04681564494944e-146

199

gi|2190337|gnl|PID|e321614

2

1.43470065809146e-120

130

gi|2506462|sp|P02188|MYG_HORSE

3

3.75183070708015e-112

138

gi|1168350|sp|P00330|ADH1_YEAST

4

7.74113710163722e-63

60

gi|122361|sp|P01966|HBA_BOVIN

5

1.50924027945192e-61

68

gi|122572|sp|P02070|HBB_BOVIN

6

9.09537575536875e-39

48

sp|P00698|LYC_CHICK

7

5.68434802614865e-33

52

gi|115453|sp|P00921|CAH2_BOVIN

8

4.17398305533061e-29

75

gi|113380|sp|P00331|ADH2_YEAST

9

1.09152586669637e-05

20

Contig7971.revised.gene2048.protein

10

0.0004899779900928

15

Contig7971.revised.gene2240.protein

The first 8 proteins are correctly identified with given probabilities in both neural net
results. Proteins with ranks 9 and 10 are not present in the sample and identified
incorrectly. In Neural Network 2 the difference in probabilities between protein with
rank 8 (correct) and protein with rank 9 (incorrect) is 28 orders of magnitude.
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For example (Table 2.3), according to the results of Neural Network 1, the likelihood of
seeing myoglobin (second hit) in the sample by chance is 3.16e-119 based on its peptide
hits. The likelihood of seeing yeast alcohol dehydrogenase II by chance, according to
Neural Network 1, is much higher, with a probability of 4.2e-3 while the first incorrect
protein has a Pscore of 3e-1.
On the more complex ISB dataset, protein identification results were found to be
significantly different by these different methods. The comparison of the four methods in
terms of sensitivity and specificity of protein identifications is shown in Figure 2.4. The
first 500 protein identifications for each method were used in the analysis, showing the
change in sensitivity and specificity based on the rank of protein identifications. The plot
was made by creating rank cutoffs for each method in incremental step of 10 from 10 to
100 consequently computing sensitivity and specificity of each method. After the
hundredth rank, the step size was increased to 100. Of the 29 proteins manually
identifiable in the ISB set, DTASelect with the normal filter found 17 proteins ranked
between 1 and 100 while Neural Network 1 found 23 proteins in the first 100 hits. A
more detailed comparison is given in figure 2.4. From this figure, we can see that Neural
Network 1 consistently outperforms DTASelect (SEQUEST) by a large margin.
However, Neural Network 2 performs significantly worse than Neural Network 1, having
identified only 62% of the proteins within the first 100 hits, while Neural Network 1
identified 79% and DTASelect with normal cutoff identified 58% (Figure 2.4). Protein
assignments based on DTASelect unfiltered, regardless of protein rank or dataset, showed
no usable specificity (Figure 2.4). The comparison of performance between the four
methods shows that overall, the neural network approach is superior to simple filtering.
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Figure 2.4 Specificity vs. sensitivity of protein detection. Comparison of sensitivity and specificity for identified proteins
between DTASelect filtered, DTASelect unfiltered and the two neural network approaches as the rank cutoffs increase for the
expected 29 proteins. Sensitivity and specificity are computed for rank windows (1-10, 1-20, 1-30 … 1-200…), as rank increases,
the specificity of identification decreases while sensitivity increased.
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DTASelect filtered lacks the sensitivity needed for protein identification in complex
mixtures. Because there is no cutoff applied at the peptide level, it is understandable that
the other three methods have sufficient sensitivity to identify most of the proteins with
different false positive rates. In particular, DTASelect unfiltered and Neural Network 2
lack practical specificity. Neural Network 1, however, provides superior sensitivity and
specificity compared to conventional methods.
Another approach for protein reliability estimation based on SEQUEST scores,
presented by MacCoss et al (MacCoss, 2002) appears very similar to the method
proposed in this chapter. The differences between the two approaches lay in the
treatment of peptide probabilities and the implications in the model of protein reliability.
MacCoss’s reliability of peptide matching appears to solely depend on the use of
normalized X-correlation score. X-correlation score is normalized through dividing it by
the autocorrelation score of the experimental spectrum; that is expected to minimize the
effect of peptide charge and length on the X-correlation. This approach to normalization
of X-correlation assumes that the users have SEQUEST source code to modify the
resulting X-correlation (as autocorrelation has to be calculated exactly as X-correlation is
in order to provide correct results). It does not take into account the effects of ∆Cn,
SpRank, and ion coverage on the probability of correct peptide identification, excluding
them from MacCoss’s Peptprob model. We expect, however, that the peptide probability
model would be improved by using these parameters, which are also often used in simple
filtering procedures. The Protprob proposed by MacCoss is depicted as a real probability
model of identifying protein from its peptides. However, it ignores an important fact of
non-unique peptides that are not an evidence of any one protein. Additionally, due to the
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greatly varied number of peptide matches per protein, the resulting probability is often
misleading. For example, from the Neural Network 1 part of Table 2.3, it is shown that
according to the Protprob the proteins that rank 1 and 7 have probability of 1 to be present
in the sample (as their probability of being identified by chance is negligibly small
comparing to 1), and the incorrectly identified proteins with the rank 9 and 10 will have
probability of detection respectively 0.99 and 0.98. The approach proposed in this
chapter is preferable, as the difference between more likely proteins and less likely
proteins is more clearly seen by the difference in exponents. It will eventually be
possible to automatically detect where the most likely cutoffs lie between correct and
incorrect protein identifications.
Significant improvement to the conventional methods of peptide filtering and
protein assignment has been demonstrated, compared to standard cutoffs. This
improvement was achieved by training a neural network, which utilizes a number of
additional parameters not usually considered in filtering. The neural network score
provides a more accurate basis for estimating peptide identification likelihood, as well as
a foundation for statistical scoring of protein assignments. The results also show,
however, that even with these improvements the methodology is far from perfect.
At the current stage of development, it remains difficult to distinguish between
the scores of small proteins present in the sample. There is also a problem in that often
times a particular peptide may be observed and counted multiple times, artificially
inflating the protein identification score. It may be possible to remedy this situation by
constructing a more complex statistical model that would involve coverage of proteins by
peptides.
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Chapter 3
Charge Determination for Low Resolution Mass Spectrometry

Some of the data presented below has been presented as Razumovskaya J., Fridman T.,
Day R., Borziak A., VerBerkmoes N., Hettich R., Uberbacher E., Gorin A., poster
presentation at ASMS 2004
Introduction
Mass spectrometry

Analysis of protein mixtures is one of the most important and difficult
technological challenges for high-throughput proteomics. Mass spectrometry is an
analytical technique that is capable of accurately measuring the mass-to-charge ratio
(m/z, where ‘m’ stands for the mass of the measured molecule, while ‘z’ represents its
charge state) of gas-phase ions originating from biological molecules. One of the most
popular instruments used today is robust, sensitive and inexpensive quadrupole ion trap
mass spectrometer used in bottom up shotgun proteomics approaches (McCormack 1997,
Martin, 2000, Shen, 2001). With all the advantages of using quadrupole ion trap
instruments for high throughput protein identification, they lack the necessary resolution
(at least under high-throughput operating modes) to measure directly the charge state of
peptides, making the determination of mass from the m/z measurement ambiguous.
While more sophisticated mass spectrometry instrumentation can record spectra with
sufficient resolution for unambiguous charge state determination, the abundance of
proteomics data generated by quadrupole ion trap instruments dictates the need for
substantial advances in computational algorithms for interpretation of spectra from these
instruments, including robust charge determination algorithms. Here a new approach for
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accurate charge state assignment is presented involving using a trained neural network to
detect charge-specific spectral characteristics.
Charge determination problem for database search algorithms

One of the main approaches to tandem MS data interpretation is database
searching. As described in the Introduction “Database search algorithms” section, a
typical database search involves scanning a protein database for potential candidate
sequences that match the experimentally observed peptide’s spectrum by such parameters
as the peptide’s m/z or a short sequence tag obtained from the peptide’s fragmentation
pattern (MS/MS spectrum) through sequencing. In this analysis every piece of
information can play a critical role in the reliable identification of the peptide. Some of
the most frequently used methods, such as mentioned SEQUEST (Eng, 1994), MASCOT
(Perkins, 1999), SONAR (Field, 2002) rely on using the peptide m/z ratio as a step for
obtaining the candidate sequences from the database. The database typically consists of
the predicted peptide masses derived from in-silico digestion of the proteins present in
the database. In order to obtain database candidate sequences that match the
experimentally measured peptide’s m/z, the masses of the theoretical peptides must be
compared to the m (mass) of the peptide, for which its z (charge) must be determined or
at least assumed. In case of incorrect mass assumption, the true peptide’s sequence does
not appear in the list of the candidate peptides leading to either no identification or a false
positive identification.
The resolution of an ion trap instrument does not allow for direct determination of
charge state of peptides by looking at the isotopic packet distances as it is done with some
mass spectrometers that are capable of higher resolution (Loo, 1992). In case of a
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peptide carrying a single charge, the CID produces MS/MS spectrum where all the real
fragment ions fall below the precursor mass. Thus the singly charged state can generally
be easily determined by comparing the percent of spectral intensity before and after the
precursor mass (95% of intensity below precursor ion generally constitutes a singly
charged peptide as mentioned in the work describing 2to3 (Sadygov, 2002)). However,
in case of higher charge states, the fragment ions can appear in different charge states, as
well as either above or below the precursor m/z. From CID spectrum of a doublycharged peptide parent ion, we can observe fragment ions of charge one or two below the
precursor m/z, and of charge one above the precursor m/z. In case of multiply charged
peptides, the spectral density alone does not allow for a good discrimination between the
charge states.
Current charge determination approaches

The widely applied approach is to differentiate between singly and multiply
charged ion spectra. Since obtaining tandem mass spectra from parent ions with charge
states higher than three is considered rare (Sadygov, 2002), all the multiply charged
spectra are considered to be either doubly or triply charged. Therefore, the charge states
of two or three are assumed and then the corresponding molecular weight for each charge
state is computed. The database search then proceeds to search for database peptides
with both calculated molecular weights. The actual charge state of a peptide is then
inferred from the results of the database search – the charge state with the higher score is
assumed to be the correct charge state with consideration for the charge dependant
increase in X-correlation. While this approach prevents loss of peptide assignments due
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to the incorrect charge determination, the search time is nearly doubled by the approach,
and the possibility of false positives is increased.
A recently published approach, 2to3, (Sadygov, 2002) assigns multiply charged
spectra to charge states +2 or +3, while the un-assignable spectra remain in the duplicate
versions. The approach is based on counting all the pairs of fragment peaks that match
the expected parent masses (for either charge 2 or charge 3) and then choosing the charge
state that accounts for the most of the fragment ions found in the spectrum.
Another relevant paper by Colinge et al (Colinge, 2003) reviews three algorithms
focused at peptide charge assignment. The algorithms are denoted as Algorithm (N) and
Algorithm (K), “posteriori charge assignment” algorithms and Algorithm (B),
“integrating observations” algorithm. Algorithm (N) involves dividing a tandem mass
spectrum into a set of intervals according to parent mass with different possible charges.
They propose designing a stochastic model to evaluate the distributions of fragment m/z
values in the specific intervals defined by the parent mass to charge ratio and compare the
modeled distributions to each of the considered spectra. Algorithm (B) is based on
complementary ions, much as previously discussed 2to3 algorithm and parent mass
correction algorithm (Dancik, 1999). The third Algorithm (B) is a combination of
Algorithm (N) and Algorithm (K).
In this chapter, a new method for charge state assignment is presented. It involves
using an artificial neural network to determine a charge state of a precursor ion based on
a set of charge-specific features found in its tandem mass spectrum. The features that are
used to differentiate between the multiple charged peptides involve: long distance
information (amino acid differences), short distance information (small neutral losses),
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the number of fragment ions consistent with possible parent masses and relative densities
of peaks in regions of the spectrum. The last two features were also used in the previous
approaches. The addition of new characteristics such as long distance information and
the short distance information coupled with a neural network allows us to significantly
improve the quality of charge determination. The results of our charge determination
show an accuracy of roughly 99% for complex samples in charge state assignment, with
only 10% of spectra with unassigned charge state.
Materials and Methods
Training sets

A protein standard mixture dataset, the “Seattle dataset”, provided by the Institute
for Systems Biology (ISB, Seattle, Washington), published by Keller et. al (Keller,
2002*), was used as the training data for the systems. It includes 18 proteins, and
additionally considers a few human contaminants, bringing the number of proteins in the
sample to 29. The peptide data used in our analysis includes 1,565 identified peptides of
charge 2 and 914 identified peptides of charge 3.
An additional dataset from a standard mixture of proteins was used for testing the
system. A protein standard mixture of eight proteins including 5442 tandem mass spectra
was prepared and analyzed by 1D-LC-ES-MS/MS. This “ORNL dataset”, was fully
described in a previous study on reliability assessment (Razumovskaya, 2004).
An Escherichia coli proteome data set, the “E. coli dataset” was used in both
testing and training. This dataset was generated from an E. coli K-12 strain grown deep
into stationary phase and analyzed by 1D-LC-MS/MS with multiple mass range scanning
and contained 35,486 tandem MS spectra. Briefly, the cells from a 2-L culture grown
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deep into stationary phase were harvested, washed twice with Tris buffer (pH 7.5) with
10mM EDTA and lysed with sonication. Four crude protein fractions were created by
ultracentrifugation (100,000g for 1 hour creates membrane and crude fraction and then
for 24 hours creates pellet and cleared fraction). Protein fractions were denatured,
reduced and digested with sequencing grade trypsin. The resultant peptide mixtures were
de-salted with solid phase extraction (C-18), concentrated and filtered to give a final
concentration of ~10µg/µL based on starting material. All tryptic digestions of all
fractions were analyzed via one-dimensional LC-MS/MS experiments performed with an
Ultimate HPLC (LC Packings, a division of Dionex, San Francisco, CA) coupled to an
LCQ DECA XP ion trap mass spectrometer (Thermo Finnigan, San Jose, CA) equipped
with an electrospray source operated at 4.5kV. Injections were made with a Famos (LC
Packings) autosampler onto a 50µl loop. Flow rate was ~4µL/min with a 240-min
gradient for each LC-MS/MS run. A VYDAC (Grace-Vydac, Hesperia, CA) C18
column (300µm id x 15cm, 300Å with 5µm particles) was directly connected to the
Finnigan electrospray source with 100µm id fused silica. For all LC/MS/MS data
acquisition, the LCQ was operated in the data dependent mode with dynamic exclusion
enabled, where the top four peaks in every full MS scan were subjected to MS/MS
analysis. To increase dynamic range in the 1D-LC-MS/MS analysis separate injections
were made with a total of 8 overlapping segmented m/z ranges scanned (referred to as
gas phase fractionation or multiple mass range scanning). The resultant MS/MS spectra
files from all fractions were searched with SEQUEST against all predicted ORFs from E.
coli. The raw SEQUEST output files were filtered and sorted with DTASelect (Tabb,
2003) with the following parameters: fully tryptic peptides only, with delCN of at least
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0.08 and cross-correlation scores (X-correlations) of at least 1.8 (+1), 2.5 (+2) and 3.5
(+3). All peptides passing these criteria were kept for further analysis.
Neural network training and testing

Stuttgart Neural Network Simulator 4.2 (SNNS) (http:/www-ra.informatik.unituebingen.de/SNNS/) was used to train an artificial neural network to assign charge states
to multiply charged peptides measured by quadrupole ion trap. The neural network
connection weights were trained using the back-propagation learning algorithms, with all
the standard parameters suggested in the SNNS package. Performance results were saved
every 60 cycles throughout the training process, the training procedure stopping when no
improvement in the error rate could be achieved. Each of the resulting nets was then
tested for performance and the best was selected based on performance on the training
and testing sets. The neural network output ranges from 0 to 10, where the output
represents the charge state of the precursor ion – 0, stands for charge 2+, while 10, stands
for charge 3+.
The three non-overlapping datasets described in the “Training Sets” section, the
ORNL dataset, the E. coli dataset and the Seattle dataset were used to train and test the
neural network for charge determination. The well-characterized, manually curated
Seattle dataset (Keller, 2002) was used for training of the neural net; it includes 1565
examples of charge 2+ tandem MS spectra and 914 examples of charge 3+ tandem MS
spectra. The method was tested on two non-overlapping data-sets acquired at Oak Ridge
National Laboratory 1) the ORNL dataset, acquired from a standard mixture of 8
proteins, and 2) the E. coli dataset, derived from a complex mixture of proteins, the
proteome of a whole organism. In order to increase the size of the training set, the high
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confidence identifications from E. coli dataset were included for ORNL dataset testing
and the high confidence identification from ORNL dataset were included in the E. coli
dataset testing, creating the unbiased non-overlapping training datasets. The high
confidence identifications included into the training sets from ORNL and E. coli datasets
were chosen as follows: all spectra assigned to charge 2+ peptides with SEQUEST’s Xcorrelation score of 2.8 and higher, (X-correlation scores of 2.5 or above are generally
required for confident identifications of charge 2+ peptides) and all spectra assigned to
charge 3+ peptides with SEQUEST’s X-correlation of 3.8 and higher (confindent
identification requires X-correlation score of 3.4 or above). The training set for ORNL
dataset included the full Seattle dataset and a filtered collection of spectra from E. coli
dataset, including 1963 examples of charge 2+ tandem MS spectra and 1001 examples of
charge 3+ tandem MS spectra. The training set designed to test the performance of the
charge determination approach on the E. coli dataset included Seattle dataset and 395
examples of charge 2+ spectra and 131 examples of charge 3+ spectra from ORNL
dataset. Thus the neural network trained with the first training set was only tested on a
non-overlapping ORNL dataset and neural network trained on the second training set was
tested on non-overlapping E. coli dataset.
Algorithmic approach

The development of the charge determination approach involved the following
three steps: 1) identifying the fragmentation pattern features that are related to the charge
of precursor ion, 2) training an artificial neural network to recognize the charge state of
the precursor ion based on the set of features found in its fragmentation pattern, 3)
selecting the neural network cutoffs for the assignment of the charge states. The rationale
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behind choosing the fragmentation pattern features is discussed in the following three
sections: “CID spectrum” and “Underlying principles” and “Charge Determining Spectral
Features”. The spectral features used for the charge identification are: long distance
information (amino acid differences) for each of the charge states considered (3
parameters), short distance information (neutral losses) (3 parameters), parent masses for
the charge 2+ and charge 3+ states (2 parameters) and relative densities below and above
parent mass (2 parameters) each of which is discussed separately in the “Charge
determining spectral features” section. Using the set of ten parameters derived from the
mentioned features we trained an artificial neural network, as described in “Neural
network training and testing” section and based on the results selected reasonable neural
network score cutoffs for the final charge state determination.
CID spectrum

Tandem mass spectrometry produces a sequence dependent fragmentation pattern
and the mass analyzer records the m/z of the resulting ions. The number of positive
charges on the parent ion (H+) determines the total charge of the peptide and therefore
real parent ion mass (PM) can be computed as follows: PM(real) = PM(observed)*charge
- charge or PM = (m/z)*z - z. As a result of CID fragmentation, a peptide tends to
fragment by breaking along the backbone bonds and creating a pair of fragments, which
if they retain a charge are referred to as ‘b’ and ‘y’ ions (Roepstorff, 1984; Biemann,
1988). The number of singly charged ‘b’ and ‘y’ ions for each given peptide is equal to
the number of the peptide bonds. A peptide containing N amino acids, has N-1 peptide
bonds, it’s CID spectrum is expected to have N-1 possible ‘b’ and N-1 possible ‘y’ ions
of charge 1+. The sum of masses between the singly charged ‘b’ and the corresponding
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‘y’ ions in tandem MS spectrum produce the mass of the parent ion PM= b + y -1, and
the sum of charges between the ‘b’ and corresponding ‘y’ ions, should produce the total
charge on the parent ion: zP=zb + zy where zp is the charge on the peptide p. Many of the
‘b’ and ‘y’ ions have been shown to have additional fragmentation, resulting in a series of
trailing peaks formed by the losses of various chemical groups, such as loss of water and
loss of ammonia, etc (Dancik, 1999, Fridman, 2003) (the considered chemical losses off
the ‘b’ and ‘y’ ions were: H, H2O, NH3, CO, CO-H2O, CO-NH3, NH3-H2O, where ‘-‘
refers to the loss of the corresponding chemical group).
Underlying principles

The main idea of the charge determination described here is based on the concept
that different charge states of a parent peptide lead to variations in the fragmentation
patterns. For example, a peptide with a total charge of 1+ will only produce fragment
ions of 1+ charge, while the same peptide with charge 2+ might produce 1+ and 2+
fragment ions, and a peptide with charge 3+ could have all the charge states present in the
fragmentation pattern, as illustrated in Figure 3.1. The peptide with total charge of 2+ is
likely to fall apart in the following patterns: ‘b’ ion of charge 1+ and corresponding ‘y’
ion of charge 1+, or ‘y’ ion of charge 2+, with unobservable neutral fragment in place of
a ‘b’ ion and conversely ‘b’ ion of charge 2+, with unobservable ‘y’ fragment ({1+,1+}
pattern or {0,2+} pattern). The peptide with total charge of 3+ can fall apart into {1+,2+}
pattern or {0,3+} pattern. It was also noted that, due to charge repulsion, protons favor to
be at a distance from each other making {1+,1+} and {1+,2+} patterns more frequent
(Figure 3.1). Since the patterns are different, it should be possible to differentiate between
the precursors of charge 2+ and charge 3+ (as well as higher charge states).
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Figure 3.1 Charge dependent patterns. The most frequently observed charge
fragmentation patterns in the SEATTLE dataset. The vertical arrows indicate the
cleavage site for each parent ion.
a. Peptides of charge 1+ fragment into an ion with 1+ charge and a neutral fragment,
b. Peptides of charge 2+ are likely to fragment into b ion with charge 1+ and a y ion with
charge 1+,
c. Peptides of charge 3+ are likely to fragment into b and y ions with one ion carrying 1+
charge and the other with 2+ charge.
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It was noted that more fragments from charge 2+ precursors carry 1+ charge with little
of 2+ charged ions, while fragments from charge 3+ precursor have roughly equal
amount of 1+ and 2+ charged ions.
Charge determining spectral features
Long range information (Amino acid differences)

Most of the software developed for interpretation of tandem mass spectra relies on
the fact that in an ideal case a peptide is expected to fragment along the peptide
backbone, producing a series of consecutive ions separated by m/z of one amino acid
residue as described in “CID spectrum” section. In the case of a continuous succession
of ‘b’ (or ‘y’) fragment ions with charge 1+, the mass differences between consecutive
ions would correspond to single amino acid masses. In the case of a series of fragment
ions with charge 2+, the mass differences should match amino acid masses divided by 2,
etc. This insight can be used to assess the number of differently charged fragment ions
present in the spectrum. It would be expected that different charge spectra have a
different number of 1+, 2+ and 3+ amino acid differences. To use this information for
charge state determination, the instances of amino acid differences of charge 1+, charge
2+ and charge 3+ are counted and weighted. Computing these weights involves the
summation of the normalized intensity products of peak pairs, whose m/z are separated
by mass of one amino acid or one amino acid divided by the respective charge. For
example, as the differences between the m/z values of all pairs of consecutive charge 1+
‘b’ (or ‘y’) ions yield to the masses of amino acids, AA1 is the sum of the product
intensities of the two consecutive ions, normalized to the square of the highest peak in the
spectrum. Since the ion identity is unknown, all the peak pairs located at the amino acid
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distances with an error of 1 Da of each other are accepted in the analysis, which
potentially includes the neutral loss ions and the noise peaks. The three charge states of
amino acids provide the three parameters (AA1, AA2 and AA3) for the long range
information in the spectrum. The contribution of long range information to the
differentiation between charge 2 and charge 3 spectra is shown on Figure 3.2a. The
separation based only on the long range information is not in itself conclusive, as most of
charge 2 and charge 3 spectra have similar scores derived from the neural net analysis.
Short range information (Event differences)

In addition to the amino acid differences, it is expected that the differences
between main ion types and their corresponding satellite peaks, described above in the
”CID spectrum” section, will be similarly affected by the charge states. Since this
information is contained within approximately 50 m/z region surrounding each b or y ion
peak, we refer to this as the “short range” information. For example, a ‘b’ fragment ion
with a charge state 1+ has a water loss ion peak 18 m/z units lighter, while a ‘b’ fragment
ion with a charge state of 2+ having a water loss ion peak only 9 m/z units lighter. The
full set of such small neutral losses that we considered in our model is listed in the “CID
spectrum” section. The procedure for computing the short range parameters is very
similar to the one described above in the section describing the “Long Range
Information”. Computing ED1 involves summation of the normalized intensity products
between the expected charge 1+ ions and their corresponding neutral loss satellite peaks,
while ED2 and ED3 are computed by summing the normalized intensities of ion pairs
located at the event masses divided by 2 and by 3 respectively. The short range
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Figure 3.2 Significance of spectral parameters for charge state determination.
The performance of charge separation by each of the four considered factors separately:
a) long range information, b) short range information, c) parent windows, d) spectral
density. The solid line stands for charge 2+ peptides, dashed line stands for charge 3+
peptides, X-axis denotes the neural network score, while Y-axis shows the number of
spectra with the given score. The parent windows factor shows the greatest separation
between charge 2+ and charge 3+ spectra.
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information provides us with another three parameters (ED1, ED2 and ED3). The short
range information in itself also fails to provide a distinct differentiation between parent
ions of charge 2 versus charge 3. Figure 3.2b demonstrates that the distributions of
scores derived from the neural net analysis for charge 2 and charge 3 spectra are fairly
broad, with considerable overlap. However, the short-range scores in Figure 3.2b provide
a more marked distinction between parent ions of charge 2 versus charge 3 than the
scores derived from amino acid differences (Figure 3.2a).
Parent windows

The concept of complementary ions is a well studied phenomenon in tandem mass
spectrometry of peptides. When a peptide dissociates into two corresponding fragment
ions, b and y, the sum of the masses of the two complementary fragment ions equals the
mass of the parent peptide. This property is extensively used by charge determination
algorithms such as those mentioned above: 2to3 (Sadygov, 2002), and Algorithm(K) and
Algorithm(B) (Colinge, 2003). When the parent m/z is measured, the mass can be
calculated with a particular assumed charge state and the summation of candidate pairs of
complementary ions can be used to deduce the correct parent mass. The true parent mass
“window” (a window of ±2 Da around given mass value) collects the sums of true
complementary pairs of fragment ions, while other assumed parent mass windows
collects random pair wise sums of m/z values. The comparison between the number of
fragment pairs that produce the possible parent mass in summation is used to determine
the likely charge state of the peptide. In our approach the procedure involves multiplying
the normalized intensities of the two corresponding ‘b’ and ‘y’ fragment ions (their m/z
values add up to a particular parent mass) and summing all the resulting products for a
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particular parent mass to produce a final parent mass score (PM). The procedure is
applied to all the considered parent masses, in the case of differentiating between charge
2+ and charge 3+ charge states, it involved computing the value for parent mass
“window” of charge 2+ (PM2) and the value for parent mass “window” of charge 3+
(PM3), creating two parameters for the charge state determination algorithm. The
potential capability of parent windows for determining the charge state is shown in
Figure 3.2c. It is undoubtedly the most powerful of all the techniques that we apply to
the charge state identification, however, it was reinforced by the addition of the other
parameters.
Relative density

In case of parent ion of charge 1+, all of the valid fragment ions fall into mass
range lower than that of the m/z of the parent ion while the mass range above the parent
ion contains no peaks that belong to the parent peptide of charge 1+. Let us divide the
spectrum into two parts: the first part with lower m/z range than the observed parent m/z
and the second part with higher m/z range than the observed parent m/z. As previously
described, in charge 1+ spectra, all the fragment ions have charge 1+, and they are
concentrated in the first part of the spectrum, with no peaks due to authentic fragments of
the parent ion in the second part of the spectrum. The approach currently used to identify
charge 1+ spectra involves the comparison of composite intensities in the first (D1) and
second (D2) parts of the spectrum. If the total intensity in the second part of the spectrum
is below 5% of the total intensity of the spectrum, the spectrum is considered to be a
charge 1+ spectrum. In case of a spectrum being produced from a parent peptide with
charge 2+, the peaks located below the parent m/z hold either charge 1+ or charge 2+,
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while all the peaks in the second part of the spectrum are of charge 1+. The reason for
this model is based on the following: all of the fragments observed in the tandem mass
spectrum must be less than or equal to the parent in mass; any fragment observed with
higher m/z than the parent m/z must have a lesser charge than the parent ion, while the
peaks below the parent m/z can have any charge from 1 up to the charge of the parent
peptide ion. As the parent charge increases, the parent m/z becomes lower, and the
fragment ions in the first region can carry higher charges. The ratio between the
intensities in the first and second part of the spectrum changes depending on the peptide
charge. A similar approach was used by Colinge, in his algorithm(N) (Colinge, 2003),
however, here it is simplified to the division of the spectrum into only two parts (which is
more realistic, considering mass to charge range), adding two parameters, D1 and D2 to
the charge determination where they are used in combination with all the other
parameters. The neural net scores for spectrum density are shown in Figure 3.2d.
Selecting cutoffs

The ten variables produced by the four contributing factors – the AA1, AA2 and
AA3 (1+, 2+ and 3+ charge state parameters from the long range information), the ED1,
ED2 and ED3 (1+, 2+ and 3+ from short range information), PM2 and PM3 (2+ and 3+
charged parent windows) and D1 and D2 (above and below parent mass densities) are
used to describe the charge state of a given spectrum. Using the training sets described in
“Training set” section, we trained and tested the separation between the charge 2+ and
charge 3+ precursor ions based on the given parameters. The results of our charge
determination for the Seattle training dataset are shown in Figure 3.3 and summarized in
Table 3.1.
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Figure 3.3 Charge separation results for the Seattle dataset. The distributions of charge 2 and charge 3 spectra by the neural
network score. The charge 2 spectra are denoted by a solid line – most of the charge 2 spectra have a score below 1; charge 3
spectra are denoted by dashed line – most of charge 3 spectra have a score higher than 8.
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Table 3.1 Charge state assignment results for neural net training with Seattle
dataset
Parent ion charge

Correct*

Incorrect*

Undecided*

+2

1546

10

9

+3

878

26

10

Percent IDs

97.74%

1.45%

0.766%

The charge assignments for Seattle dataset *relative to the manually curated assignments
(Keller, 2002)

Since the Seattle dataset was manually curated, all the charge states for the tandem MS in
the dataset are considered correctly pre-assigned. The charge state discrimination
presented in Figure 3.3 is significantly better defined than in any of the four contributing
factors shown in the Figure 3.2. Most of the charge 2 spectra are shown to have a neural
network score below 1, while most of charge 3 spectra have a score higher than 8. Based
on the analysis which minimizes the erroneous assignments (increasing the number of
undecided assignments), all the spectra with score less or equal to 1 are considered to be
a product of charge 2+ peptides, while all the spectra with score greater or equal to 9 are
considered to be a product of charge 3+ peptides. The peptides with scores between 1
and 9 are the “unassigned spectra”, which will be subjected to SEQUEST analysis as
both possible charge 2+ and charge 3+ spectra. The results show a rate of incorrect
charge state assignment of 1.45% and unassignable spectra rate of 0.8% for Seattle
dataset (36 spectra out of 2479 would have been incorrectly assigned and 19 spectra
would have been considered as both charge 2 and charge 3 peptides). The absence of any
single given parameter decreased the efficiency of charge separation in the training set.
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Results and Discussion

The charge determination algorithm for low resolution quadrupole ion trap mass
spectrometer promises an improvement to high throughput data interpretation in two
main aspects: it is capable of significantly decreasing the number of false positive
identifications and the increase of the speed of the analysis. It is difficult to ascertain the
rate of false positive identifications made by search algorithm like SEQUEST, the only
methods for such analysis are generally increasing the search space (by increasing the
database size) and comparison to other algorithms. Here, we attempt to examine the
SEQUEST’s performance in a different manner – by comparing the performance of the
described charge state determination algorithm to the performance of SEQUEST’s charge
state assignment under different X-correlation cutoffs. The performance of the described
method is not affected by the changing X-correlation cutoffs, however, as they are
increased the number of true positive SEQUEST’s assignments increases and the true
performance of the charge state algorithm can be seen. The true performance exhibited
by our method for a real proteomic sample at 0.6% error and 10% unassigned spectra at
highest X-correlation suggests that at the accepted X-correlations, the charge
determination algorithm will be able to reduce the number of false positives from the
1.8% shown at X-correlation of 2.6 for charge 2+ to 0.6% while the number of
unassigned spectra will be 17.7%.
One of the problems in measuring the error rate of bottom up data interpretation
algorithms is that it is difficult to obtain a large set of correctly assigned peptides. If the
dataset contains accepted 5% of incorrect identifications, the percent error of the tested
method cannot be lower than 5%. In our test cases (the non-manually curated ORNL
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dataset and E. coli dataset), we had to rely on SEQUEST database search to produce
correct peptide assignments for our training and test sets, however, there is no guarantee
that all the assignments used in the analysis are correct. The peptide assignments are
mainly based on particular set of cross-correlation (X-correlation) cutoffs derived from
SEQUEST and different laboratories apply different cutoffs for their peptide
identification. The high X-correlation cutoffs used for the training sets reduce the
number of false identifications, however, with the increasing cutoffs the number of
unidentified peptides also increases making the analysis unrealistic. In order to
circumvent the problem of inflated error, we present a scheme to measure the
performance of the charge determination algorithm independently of the static Xcorrelation cutoffs. The algorithm’s performance is displayed in Figure 3.4 for different
ranges of X-correlation cutoffs, to show the relationship between the accuracy of peptide
sequence identification and charge state assignment. For charge 2+ peptides is Xcorrelation cutoffs are varied in the range from 1.0 to 3.8, in increments of 0.2. The
charge 3+ X-correlation cutoffs range from 2.0 to 4.8 in increments of 0.2. As the Xcorrelation cutoff is increased, the number of false positive identifications decreases, the
percent of SEQUEST’s incorrect identifications is negligibly small with very high Xcorrelation cutoffs (as 3.5 for charge 2+ peptides and 4.5 for charge 3+ peptides). When
the percent of incorrect identifications is reduced, the real performance of our algorithm
can be observed. This performance measure should provide an accurate assessment of
error rate of our algorithm, as well as provide the expectation of the algorithm’s
performance based on any set of cutoffs.
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Figure 3.4 Estimation of error rates for charge state assignment in E. coli and ORNL datasets. The solid curves represent
the percent of error made by the charge determining algorithm as comparing to the SEQUEST charge assignment, the dashed
lines stand for the percent of spectra that the charge determining algorithm considered unassignable as comparing to the
SEQUEST charge assignment.
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There are two measures of error for the performance of a charge determination
algorithm: the number of incorrectly assigned charge states, and the number of spectra for
which charge could not be determined. The two characteristics are connected – it can
generally be adjusted whether more spectra should be assigned (potentially producing
more incorrect assignments), or more unassigned spectra can be allowed (reducing the
number of erroneous assignments, but increasing the number of spectra with multiple
charge states). The performance of our method was tested against two test sets, the
ORNL dataset and the E. coli dataset, as shown in Figure 3.4 and summarized in Tables
3.2 and 3.3.
The percent of false positive assignments made by SEQUEST is expected to
decrease with the increase of X-correlation cutoff. At the low X-correlation cutoffs (1,
for charge 2+ peptides and 2 for charge 3+ peptides) both datasets show high error rates:
19% error for the ORNL dataset and 27% error for the E. coli dataset. However, as
expected, when the X-correlation cutoffs are increased reducing the number of false
identifications, the percent error of our charge state assignment method decreases
dramatically. At the frequently used X-correlation cutoffs of 2.6 for charge 2 and 3.6 for
charge 3, the percent errors in charge state determination are 2.8% and 1.8% for ORNL
dataset and E. coli dataset respectively. At the higher X-correlation cutoffs, the decrease
in charge state assignment error as a function of X-correlation levels off. At the highest
X-correlation cutoff considered: X-correlation 3.8 and 4.8 for charge 2 and charge 3
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Table 3.2 Charge assignments for the ORNL dataset.
X-correlation

%Error

%Undecided

Charge 2

Charge 3

2.2

5.0

14.4

528

193

2.4

3.3

11.4

475

165

2.6

2.8

10.1

431

141

2.8

2.8

9.1

395

131

3.0

2.7

8.5

363

118

3.2

2.5

7.8

331

104

3.4

2.5

7.4

303

89

3.6

2.0

7.08

275

77

3.8

1.6

5.8

248
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The first column refers to the presented X-correlation cutoffs for charge 2+ peptides,
corresponding X-correlation cutoffs for charge 3+ is greater by 1. Second column shows
%error made by charge assignment method, SEQUEST assignments with given Xcorrelation cutoffs are correct. Third column displays the percent of unassigned spectra,
while fourth and fifth columns show the number of SEQUEST assignments for charge 2
and charge 3 peptides in the database.
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Table 3.3 Charge assignments for E. coli dataset.
X-correlation

%Error

%Undecided

Charge 2

Charge 3

2.2

4.4

21.5

2874

1515

2.4

2.6

19.2

2475

1326

2.6

1.8

17.7

2203

1149

2.8

1.3

16.6

1963

1001

3.0

1.1

15.1

1740

862

3.2

0.8

14.3

1501

740

3.4

0.6

13.1

1273

634

3.6

0.5

11.3

1066

520

3.8

0.6

10.1

875

438

The first column refers to the presented X-correlation cutoffs for charge 2+ peptides,
corresponding X-correlation cutoffs for charge 3+ is greater by 1. Second column shows
%error made by charge assignment method, SEQUEST assignments with given Xcorrelation cutoffs are correct. Third column displays the percent of unassigned spectra,
while fourth and fifth columns show the number of SEQUEST assignments for charge 2
and charge 3 peptides in the dataset.
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peptides respectively, ORNL dataset shows 1.6% error, while E. coli dataset shows 0.6%
error. These final numbers approximate the accuracy of our charge determination as
compared to X-correlation cutoffs, since as X-correlation decreases, the less SEQUEST
assignment contributes to the percent of error in the analysis. Thus, for the ORNL
dataset, the charge assignment’s error is approximately 1.6% (based on the highest Xcorrelation cutoffs), and for the E. coli dataset, the error is approximately 0.6%.
The percent of unassigned spectra behaves similarly to the percent error, as the Xcorrelation cutoffs increase. For relatively low X-correlation cutoffs of 1 and 2 for
charge 2+ and charge 3+ peptides respectively, the ORNL dataset shows 19% unassigned
spectra, while the E. coli dataset displays 38% unassigned spectra. At the X-correlation
cutoffs of 2.6 for charge 2+ and 3.6 for charge 3+, 10% of spectra are unassigned in the
ORNL dataset, while the E. coli dataset shows 18% unassigned spectra. At the Xcorrelation cutoffs of 3.8 for charge 2+ and 4.8 for charge 3+, the ORNL dataset has
roughly 6% of spectra with unassigned charge state, and the E. coli dataset shows 10% of
spectra with unassigned charge states. The spectra that fall under the classification of
being undecided will be searched as either charge 2+ and charge 3+ spectra, therefore
they will not be lost as identifications as the ones whose charge was assigned incorrectly.
The disadvantages to having unassigned spectra are that they increase the search time of
the algorithm and that they cause incorrect assignments on the peptide levels. However,
it is important not to loose possible identifications by making incorrect charge state
assignments, thus as long as the number of unassigned spectra is not overly large (greater
than 20%), it is beneficial to open the windows for a few more unassigned spectra rather
then cause increase in error rate, leading to unidentified spectra.
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Some of the differences between the our method’s performance for the two
datasets can be explained by the nature of the data: ORNL dataset, like Seattle dataset is
very limited in number of peptides, while E. Coli dataset is a real life complex mixture
with significantly larger number of peptides in every range of scoring. As shown above,
the differences between the datasets are displayed by both the error percent and the
percent of unassigned peptides (ORNL dataset: error 1.8%, unassigned 5.8%; E. coli
dataset: error 0.6%, unassigned 10%). These differences point at the different
distributions of charge 2+ and charge 3+ spectra as a function of the neural network score
(Figure 3.3), which affects the percent error and percent undecided. It is possible to
change the neural network score cutoffs for charge 2+ spectra and charge 3+ spectra to
produce similar percent of errors and undecided for both datasets.
The algorithm has been trained on the data received from two ion trap instruments
from different laboratories (ISB and ORNL). It appears that the performance is best if
the neural network is partially trained on the data available from the instrument where the
data is analyzed, it is at this time unknown whether it is due to the instrumental
differences or the differences in the experiment or the quality of data. At this time, the
best performance shown by the charge determination method was in application to real
proteomic data rather than the standard datasets where the protein content is assumed as
known. In part, the reason for this phenomenon might be caused by the practice of
accepting most of SEQUEST’s identifications which correspond to the expected proteins,
even though such identification might still be coincidental.
The neural network charge state determination method combines an extensive
study of features of tandem MS spectrum with the pattern recognition of neural networks.
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It embraces a combination of known and new observations in the MS/MS spectra such as
examining the number of peaks consistent with parent masses, the spectral densities and
the long and short range spectral information. The added features and the new intensity
based schemes increase the sensitivity and accuracy of charge state determination, and
neural network allows for the normalized score estimating the likelihood of a charge state
for a tandem MS spectrum. In the future, this algorithm is easily extensible to the higher
charge state models using trivial addition to the feature parameters. This new approach is
a promising new method for charge state determination for low resolution mass
spectrometry, which can be used to improve the specificity and time of high-throughput
mass spectrometric data analysis.
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Chapter 4
Computational Identification of Post-Translational Modifications from Shotgun
Mass Spectrometry Data.

Some of the data presented below has been presented as Razumovskaya J., VerBerkmoes
N., Hurst G., Uberbacher E., poster presentation at ASMS 2005
Introduction

The proteome can be defined as the set of all expressed proteins in a cell, tissue or
organism. Proteomic analysis is the product of the need to understand the function of
proteins. Proteomics gives us insight into the interactions between proteins, allowing us
learn more about the complex network of molecular interactions. Now, as more and
more is revealed about proteins, protein structure and function, we find ourselves looking
for a deeper knowledge of protein-protein interactions and protein pathways, which gives
us a clue to the mechanics of life. The task of identifying and modeling protein pathways
is challenging and introduces a great degree of complexity to the studies, as it is a multiparametric dynamic system. The protein pathways, such as kinase signaling pathway,
involve multiple proteins interacting at different times. Additionally, it often involves
protein regulation with post-translational modifications, which is essential to the process.
Post-translational modifications (PTMs) are covalent processing events that change the
properties of a protein by proteolytic cleavage or by addition of a modifying group to one
or more amino acids. Far from being mere protein decorations, PTMs of a protein can
determine its activity state, localization, turnover and interactions with other proteins.
For example, “kinase cascades are turned on and off by the reversible additions and
removal of phosphate groups, and in the cell cycle ubiquitination marks cyclins for
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destruction at defined time points.” (Mann, 2003). The study of PTMs of proteins is,
therefore, absolutely essential to facilitate our understanding of cellular processes.
Post-translational modifications

A post-translational modification (PTM) is a modification to a protein which
occurs after its translation, causing the protein to appear in altered form from the one
originally suggested by its DNA sequence. PTMs can be in a form of proteolytic
cleavage such as a signal peptide cleavage, or a covalent addition of various chemical
groups to one or more amino acid residues. PTMs are important for protein function:
they can control the protein’s activity, be related to protein’s localization, and have an
effect on protein-protein interactions (Mann, 2003). At this time, a large number of
different PTMs has been observed in eukaryotic and prokaryotic organisms. RESID, one
of the available databases of post translational modifications, reports 330 confirmed
PTMs (Garavelli, 2004), but it is expected that the actual number is significantly greater.
Some of the more commonly observed post-translational modifications include
1)phosphorylation which is involved in regulation of enzyme activity and signaling;
2)acetylation which affects the protein stability (protection of N-terminus) and regulation
of protein-DNA interactions, 3)methylation, regulating of gene expression, 4)acylation,
cellular localization and targeting signals, membrane tethering, mediator of proteinprotein interactions; 5)hydroxyproline, protein stability and protein-ligand interactions,
6)sulfation, modulator of protein-protein and receptor-ligand interactions; 7)deamidation,
possible regulator of protein-ligand and protein-protein interactions, also a common
chemical artifact; 8)glycosylation, cell-cell recognition/signaling, reversible, regulatory
functions (Mann, 2003). Other PTMs, like disulphide-bond formation seem to be only
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involved in protein structure stabilization, or like GPI anchor, in membrane tethering.
The main PTMs found in prokaryotes include phosphorylation, methylation, loss of the
first methionine, and acetylation. Some PTMs have only been so far observed in
eukaryotes, which might suggest their later evolution, or is just related to our current
inability to perform a whole proteome PTM analysis.
Methods to measure PTMs

Several approaches have been used to attempt the study of PTMs on the
proteomics scale. Some PTMs can be predicted from DNA sequence by computational
methods, like signal peptide cleavage, and some by homology to the previously observed
proteins (like kinase cascades) in different organisms or pathways. The unknown PTMs
are very difficult to detect; many of them have been uncovered by accident during studies
of particular proteins, or specific pathways. The study of post-translational modifications
in an organism is made difficult by the nature of PTMs: generally, they can only be found
on the protein level, the DNA and mRNA do not carry the information about most PTMs.
Edman degradation (Edman, 1950) and various mass spectrometry methods have been
the most successful to detection. However, Edman degradation involves analyzing pure
proteins, which prohibits a high throughput analysis; additionally, the candidates for
Edman degradation must come from some prior analysis. Therefore, while the Edman
degradation technique is useful for identifying and localizing PTMs on specific proteins
of interest or as a confirmation technique, it cannot be practically applied to a whole
genome study.
Post-translational modifications are post-processing events that generally change
the mass of the proteins from the original mass prescribed by the DNA sequence as is
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illustrated in the figure 4.1. Since PTMs affect the mass of a protein, such techniques as
2-D PAGE and mass spectrometry that measure protein mass can be applied to detecting
the mass change and characterize present post-translational modification. While the
combination of isoelectric point information and molecular weight provided by 2-D
PAGE separations has been shown useful for detection of post-translational
modifications, 2-D PAGE separations coupled to various mass spectrometric methods
provides significant additional improvements (Wilkins, 1999).
Despite the presence of many other mass spectrometric techniques, shotgun
bottom up mass spectrometry is one of techniques that are most widely used for a high
throughput whole proteome analysis (Pandley, 2000). Using this technology it is possible
to analyze the whole proteome under varying growth conditions and at different stages of
development to be able to monitor the changes in the dynamics of the proteome. Bottom
up proteomics is a method that can be used to detect PTMs in a comparatively highthroughput fashion in a whole proteome data. However, mass spectrometry requires
computational algorithms to evaluate and interpret the measured information and
detection of post-translationally modified proteins is a challenging problem in terms of
current computational technology.
The three types of software tools that are currently applied to MS data
interpretation and are used for PTM analysis are de novo and hybrid algorithms and
database searches. At the moment, the de novo and hybrid algorithms are not up to the
standards of high-throughput proteomic data interpretation, in general, exhibiting high
rates of incorrect identifications. In many cases, these approaches are limited by the
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Figure 4.1 Post translational modifications. Example of the effect of PTM on protein
sequence and it’s impact on bottom up mass spectrometry analysis. The peptides marked
in red contain change in mass that can only be detected by special analysis considering
PTMs.

quality of data produced by MS instruments as they are more sensitive to the quality of
data than the database searches. Thus, though they are not inherently suited for PTM
detection, for proteomic experiments on ion trap instruments, database searches currently
remain the method of choice.
As previously mentioned, the peptide identifications made by database search
algorithms are based on comparisons between the fragmentation patterns of theoretical
and experimental peptides, where theoretical fragmentation patterns are derived in silico
from the available database and experimental fragmentation patterns are measured by
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mass spectrometer from a peptide found in a sample. Database searches are at the
moment considered the most reliable of the MS data interpretation tools for the shotgun
proteomic experiments, however, they are extremely sensitive to database deviations, any
peptides inconsistent with the database by mass or sequence are unidentifiable by this
method. Since PTMs change the mass of the peptides, these deviations from the database
are generally fatal, as they often prevent placing the appropriate peptide into the
candidate list formed by parent mass. Such inconsistency between the database mass and
the peptide present in the sample is illustrated above in the figure 4.1 which outlines two
avenues for PTM occurrences: the simple signal peptide cleavage and the addition of two
covalent modifications to the sequence. In either of these cases, the masses of affected
(modified) peptides are inconsistent with the masses present in the protein database
causing errors in identifications. It is noted that with the current methods of peptide
identification only 10-30% of all tandem MS spectra in a proteomics sample are
identified (the rest are either discarded, or receive such low scores that they cannot be
considered to be correct answers). While some of the spectra could be of inferior quality
or carry single amino acid substitutions, it is currently unknown what percentage of the
remaining 70% of peptide spectra may contain post translational modifications. The
attempt to analyze PTMs is built into database search algorithms. As proposed by Yates
et al (Yates, 1995), the PTM analysis performed by database searches involves placing all
PTMs of interest into all possible places in peptide sequences. This approach to analyze
PTMs leads to a large combinatorial problem, even for a small number of PTMs;
additionally Yates et al. indicated that “extending this approach to a larger set of
modifications is an open problem”. This approach is not up to the task in terms of speed
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and accuracy of the identifications; in addition it relies entirely on the user to provide a
limited list of PTMs to search during each run.
The database search algorithms are currently considered the most robust system
for peptide identification, but they are not inherently suited to solving the problem of
identification of PTMs, as they have to rely on the database sequences to be exact
representations of the parent peptide. The only way to circumvent the problem of PTM
detection by database search lays in the organism specific database annotation. As of
now, with an exception of ProSight PTM (LeDuc, 2004) designed for intact protein
analysis, there is no organism specific PTM database annotation, and without a coherent
strategy of PTM identifications, the database size quickly becomes unmanageable,
increasing the time of analysis and the number of false identifications. In addition 4060% of genes in current genome annotations are hypothetical proteins (Blattner, 1997;
Fraser, 1995; Heidelberg, 2002; Larimer, 2004) which may never be expressed in the
organism, but can add an enormous number of false identifications. In many cases PTMs
identified by database searches must be manually confirmed as to accuracy and biological
significance of the identification (how likely a particular protein is to carry a certain type
of post-translational modification based on prior studies). While further experiments
must be performed to corroborate the presence of the PTM detected by shotgun bottom
up mass spectrometry, an additional insight to the accuracy of detection is invaluable to
target further studies.
One of the major sources for incorrect identifications of peptides by database
search algorithms is due to the increasing of the database size, which causes an increase
in the number of candidate sequences. As the result of many similar candidate sequences
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present in the database, many of them might produce comparable scores. A thorough
search for PTMs increases the database sizes dramatically: for example, a possible
phosphorylation, which in principle may affect any tyrosine, serine or threonine (and in
case of prokaryotic organism histidine) in the sequence, can easily increase a database
hundreds of times, since every peptide containing any of these common residues may be
modified once, or multiple times depending on the number of these residues. In addition
to the increasing number of false positives, such thorough search can lead to days of
computational time and all the results should be manually confirmed to ensure that they
are biologically sound. All of these factors severely limit the ability of current database
search algorithms to perform a comprehensive all proteome PTM detection, leaving us
with a capability of detecting no more then a few PTMs at a time while the likelihood of
correct detection is frequently uncertain. The algorithmic approach presented in this
chapter guarantees that all the detected PTMs are biologically sound, by utilizing all the
current knowledge about post-translational modifications. This approach provides a new
way for PTM driven database annotation, which includes the combination of the prior
knowledge of PTM carrying domains in multiple organisms, homology inference and
basic PTM prediction software.
Rhodopseudomonas Palustris is a prokaryotic microbial organism commonly
found in water and soil. It is equipped to endure an extensive range of growth conditions:
aerobic to anaerobic, as well as dark to light as illustrated in the Figure 4.2.
In the light conditions, the bacteria are capable to convert light into cellular
energy. In the absence of oxygen it converts atmospheric CO2 into biomass. It is also
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Figure 4.2 R. palustris growth conditions. The four metabolic growth conditions for R. palustris are aerobic, anaerobic,
chemoautotrophic and photoautotrophic. The PTM analysis was applied to each of these growth conditions.
Adapted from Larimer et al. 2004.
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capable of degrading organic compounds including toxins like 3-chlorobenzoate building
blocks. In the presence of oxygen, R. palustris generates energy by degrading carbon
containing compounds (such as sugars, lignin-monomers, etc) and carrying out
respiration. R. palustris is one of the most metabolically versatile bacteria described at
this time. R. palustris was recently sequenced (Larimer, 2004), revealing the genome
sequence of the 5,459,213 base pair circular chromosome, with 4,836 predicted genes.
The careful study of the predicted genes showed that 31% of genome is devoted to
energy metabolism and cellular processes, 14.5% of genome to transport, 4.7% to signal
transduction. About 3.5% of the genome may carry PTMs as showed by the preliminary
analysis based on COGs (Tatusov, 1997) homology comparison of functional domains
with multiple organisms. Due to its ability to degrade toxic compounds, R. palustris
became an organism of interest for Department of Energy (DOE) and multitude of mass
spectrometric data is being collected for the analysis of the organism’s proteome
(VerBerkmoes et al., 2005) (http://compbio.ornl.gov/rpal_proteome/) and protein
complexes.
In this chapter a new algorithmic approach to PTM detection is introduced and
applied to analyzing R. palustris under a variety of metabolic growth conditions. The
new PTM discovery driven approach for shotgun bottom up MS data interpretation is
focused on utilizing all of the current knowledge about post-translationally modified
proteins to address the limitation of current database search algorithms in terms of PTM
detection. The methodology for designing PTM annotated protein domain library is an
extension to the one proposed in the ProSight PTM introduced by LeDuc in (LeDuc,
2004) for intact protein analysis (“top down” analysis (McLuckey, 1998)), which was
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successfully applied to the yeast PTM analysis by Meng et al (Meng, 2004), here applied
to high-throughput bottom up MS data. Our new PTM detection approach uses all the
current knowledge of PTM proteins and protein domains to annotate R. palustris
sequence database using the newly developed algorithmic approach PTMsearch performs
proteomic PTM analysis for bottom up MS of R. palustris.
Materials and Methods
Rhodopseudomonas Palustris sample preparation

All datasets were kindly provided by VerBerkmoes et al (VerBerkmoes et al,
2005) and their generation is briefly described below.
Cell growth, production of protein fractions and proteome digestion

R. palustris strain CGA010, a hydrogen-utilizing derivative of the sequenced
strain (unpublished C.S. Harwood) and referred to here as the wild-type strain, was
grown under the six conditions (photoheterotrophic, chemoheterotrophic,
photoautotrophic, photoheterotrophic with nitrogen fixation, photoheterotrophic with
benzoate as a carbon source). All cultures were grown anaerobically in light or
aerobically in dark, with shaking in 1.5 liters of defined mineral medium at 30°C to midlog phase (OD 660nm = 0.6). All anaerobic cultures were illuminated with 40 or 60 W
incandescent light bulbs. Carbon sources were added to a final concentration of 10 mM
succinate (for all growth modes except benzoate and photoautotrophic), 3 mM benzoate
(benzoate growth) or 10 mM sodium bicarbonate with H2 gas in the head space
(photoautotrophic growth). For the photoheterotrophic N2 fixing cultures, ammonium
sulfate was replaced by sodium sulfate in the culture medium and N2 gas was supplied in
the head space.
81

Cell extracts were prepared as follows: cells were harvested by centrifugation, washed
twice with ice-cold wash buffer (50 mM Tris-HCl buffer (pH 7.5) with 10 mM EDTA)
and resuspended in ice-cold wash buffer. Cells were then lysed by sonication and
unbroken cells were removed with low-speed centrifugation (5,000 g x 10 min). Four
proteome fractions were created from this cellular extract by ultracentrifugation (100,000
g for 1 h led to membrane and crude fractions; this supernatant was then further
centrifuged at 100,000 x g for 18 h leading to pellet and cleared fractions). All four
proteome fractions were analyzed as below.
Proteome fractions from each growth state were processed by the same protocol:
Briefly, proteome fractions were denatured, reduced, digested with sequencing grade
trypsin and de-salted by solid phase extraction.
LC-ES-MS/MS analysis

The four proteome fractions from each growth state were analyzed in duplicate
via multiple one-dimensional LC-ES-MS/MS experiments performed with an Ultimate
HPLC (LC Packings, a division of Dionex, San Francisco, CA) coupled to an LCQDECA or LCQ-DECAXPplus quadrupole ion trap mass spectrometer (Thermo Finnigan,
San Jose, CA). To increase dynamic range in the 1D-LC-ES-MS/MS analysis, separate
injections were made with a total of 8 overlapping segmented m/z ranges scanned
(referred to as gas phase fractionation or multiple mass range scanning). These entire
datasets were used in this study.
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PTM fragmentation

The PTMs that modify a protein by covalent additions of chemical groups can be
classified into three basic categories based on the binding strength of PTM to the peptide
and their impact on the MS fragmentation pattern. The modifications can be “extremely
labile”, “labile” and “stable”(Figure 4.3), based on their behavior during the analysis as
mentioned by Mann et al. While is frequently difficult to predict the full impact of
modification on the tandem MS fragmentation, the figure illustrates how different types
of modifications might affect the tandem MS fragmentation pattern of a peptide, making
the analysis of modified peptides more difficult due to the inconsistencies between the
experimental tandem MS spectrum of a modified peptide and the theoretical spectrum of
a candidate peptide.
1. The “extremely labile” PTMs (such as serine/threonine phosphorylations) have a
propensity to fall off the peptide during CID very easily, creating a dominating
fragment ion in the tandem MS spectrum. The spectra with this type of
modification generally take the form of a single major peak at Precursor mass –
PTM, as illustrated in Figure 4.3a.
2. The “labile” PTMs are significantly more stable during the fragmentation than
the “extremely labile” PTMs, only some proportion of the PTM falls off during
fragmentation of parent ion, causing a potential fragment ion at the mass of
Precursor mass – PTM . Additionally the ‘b’ and ‘y’ fragment ions also proceed
to lose some proportion of the PTM causing satellite peaks to the ‘b’ and ‘y’ ions
in the form of ‘b’ ion - PTM and ‘y’ ion - PTM ions in the fragmentation pattern,
as illustrated at the Figure 4.3.b.
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Figure 4.3 Effect of post-translational modifications on fragmentation patterns.
The examples of tandem MS spectra for the three types of PTMs: a. “extremely labile”
PTM, b. ”labile” PTM, and c. “stable” PTM.

3. The “stable” PTMs tend to be firmly attached to the peptide. The bond between
PTM and side chain is not easily breakable. As shown at the Figure 4.3.c, the
spectrum does not have any indication of the presence of a post translational
modification as in previous 2 cases since the PTM does not fall off the peptide
during the fragmentation. The tandem spectrum offers the same type of
sequencing information that is present in spectra with no PTMs.
For some of the PTMs, the fragmentation behavior is already known, and some have not
yet been observed through mass spectrometry. These different types of PTM behavior
tend to significantly alter the characteristics of the theoretical mass spectrum, and can
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create considerable difficulties for PTM detection with conventional database scoring
schemes.
Building PTM library

Over the past decades, the relationships between protein function and post
translational modifications have been observed in different organisms. The fact that
presence of a PTM in a protein is expected to have functional significance, leads to a
conclusion that homologous proteins are likely to have the same PTMs. Based on this
assumption, we use the homology between proteins to predict a presence and localization
of a PTM as it is done for protein functional annotation. In order to detect biologically
important post translational modifications, we created a comprehensive library of
proteins that have been documented to carry PTMs in multiple organisms – PTMLib.
RESID database (Garavelli, 2004) is a comprehensive collection of annotations and
structures for protein modifications including amino-terminal, carboxyl-terminal, peptide
chain cross-link and many other PTM types. Currently RESID database contains over
330 residues either predicted or observed in proteins arising through natural
modifications of encoded amino acids, which include N-formyl methionine,
selenocysteine and pyrrolysine. The creators of RESID database focused on creating a
database which documents experimentally detected post translational modification, the
protein sequences where they were found and the literature references.
The PTMs documented in the database also contain references to PIR and/or
Swiss-Prot sequences where they were discovered. This database is continuously
increasing as more data is being collected, the new experimentally verified entries of
PTMs are added at an average of 15 per year. Each RESID database entry, as shown in
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Figure 4.4 presents a chemically unique modification and shows how that modification is
currently annotated in the protein sequence databases, Swiss-Prot (Farriol-Mathis, 2004)
and the Protein Information Resource (PIR). The database is becoming an invaluable
tool for further studies of post translational modifications. The RESID database is
available at http://pir.georgetown.edu/pirwww/dbinfo/resid.html.
The post-translationally modified proteins documented in the RESID database,
the information about their corresponding PTMs and the site specificities were extracted
from RESID database and used for the creation of global PTM annotated protein library
PTMLib. Each entry in the PTMLib database specifies a protein, the post translational
modification it can carry and the annotated possible PTM target sites. The final PTMLib
database includes 223 types of post-translational modifications in 326 different proteins.
PTM annotation of R. palustris was performed based on the protein similarity
allowing location of potentially modified sites for a large number of post-translational
modifications with experimental proof. The annotation of R. palustris for putative posttranslationally modified proteins was achieved by running BLAST (Altschul, 1990;
Altschul, 1997) searches between the proteins present in PTMLib and the sequences
found in the R. palustris genome. All sequences with BLAST E-score < 10-3 were
included into the candidate PTM sequences. The PTM annotated R. palustris database
contains 287 proteins annotated for 220 different post-translational modifications.
The PTM target sites were annotated by the PROSITE pattern search (Hofmann, 1999;
Falquet, 2002). PROSITE is a search tool, which using a large collection of biologically
meaningful PTM signatures is designed to detect short PTM patterns in the given
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Figure 4.4 Example entries in the RESID database.
The database entry shows the name, molecular weight of the modification, keyword under which they are frequently found, and
reference to the protein(s) where PTM was found. It also contains the protein sequences, the PTM binding sites and references to
the journal articles describing the evidence of the PTM’s presence.
http://pir.georgetown.edu/pirwww/dbinfo/resid.html.
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sequence. While in many cases, PROSITE tends to give a greater number of possible
modification sites than can be expected, when the database is limited to the proteins with
expected PTMs and the PTM types are known, the number of PROSITE predictions is
quite tractable. PROSITE is freely available at:
http://pir.georgetown.edu/pirwww/search/patmatch.html. The new R. palustris PTM
annotated database improves searches against multiple post-translational modifications
both in terms of search time and management of number of false positive identifications.
The PTM detection database search approach

The new approach to PTM analysis involved building a search engine that would
allow searching for any number of post-translational modifications (number of
modifications searched for in R. palustris was 220) at a time. A new database search
approach (PTMsearch) was developed in order to perform the searches for posttranslational modifications in R. palustris. The PTMsearch was modeled after the widely
used database search algorithm, SEQUEST (Eng, 1994), with the basic peptide parent
mass used as a filter for candidate peptides and the use of cross-correlation scoring
scheme based on the published SEQUEST’s scoring scheme, X-correlation. The
PTMsearch differs from SEQUEST by allowing only annotated PTMs in a given
sequence as specified in the database, and allowing only one expected PTM in a peptide
sequence at one time. In addition, PTMsearch is extended to detect PTMs receiving
relatively low scores, since some of PTMs can significantly alter the appearance of a
fragmentation pattern. Thus, PTMsearch is capable of incorporating in the further
analysis all the candidate peptides including the ones that do not appear with the top ten
scores, as it is done in SEQUEST, which improves the sensitivity of the method for PTM
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detection. The use of PTMsearch greatly reduces the number of runs that have to be
made by SEQUEST to perform the analysis since only SEQUEST run allows for a
maximum of 3 post-translational modification at one time, it reduces the number of false
identifications made by SEQUEST when any number of modifications is allowed in one
peptide and allows to detect peptides with lower scores.
PTMsearch approach ensures that all the detected PTMs are found in expected
sequences, however in a novel approach, additional measures had to be taken to improve
the likelihood of the identifications. Therefore, an additional filtering approach was
introduced to increase the confidence of the detected post-translational modifications.
The filtering scheme for PTM detection in R. palustris by PTMsearch was set up to
involve a set of conditions, which are used to accept or reject an identification made by
PTMsearch. The conditions are established to reduce the number of false positive results
while retaining most of the reliable PTM detections. The conditions for accepted PTM
detection include: 1) appropriate scoring cutoffs, 2) growth conditions, 3) number of
occurrences.
The scoring cutoff condition refers to the range of PTMsearch scores that can be
accepted for peptide identification. Though the scoring scheme used in the PTMsearch is
modeled after the X-correlation, it is not an exact replica of X-correlation and while there
is a direct correlation between X-correlation and the PTMsearch scoring scheme, the
scoring cutoffs for confident identification are not as well explored as for X-correlation.
In addition to this consideration, as mentioned above in a section on “PTM
fragmentation”, the “labile” and the “extremely labile” PTMs produce a different
fragmentation pattern than the expected fragmentation pattern described in the
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“Fragmentation pattern” section of introduction. Because of these factors, the scoring
scheme behaves in an unpredictable manner when detecting post-translational
modifications and the score cutoff conditions were lowered to include most of the
identifications, including the identifications which are not the top candidate peptide.
The growth condition cutoff refers to identifying PTMs only under appropriate R.
palustris growth conditions when they are known. As an example, uridylation is a posttranslational modification that is known to be present during the nitrogen-fixing
conditions in P-II proteins. The only accepted identifications containing uridylation in PII proteins were made under nitrogen-fixing growth conditions. Unfortunately, in many
cases, the conditions in which a PTM is expected to be present are not definitively known
or they have only been detected in a limited set of conditions. This condition is only used
if the number of detected PTMs is unmanageably large since it can be extremely limiting.
It is suggested to be used only as a final confirmation of the PTM presence after
additional experiments have been performed.
The number of occurrences condition refers to the number of times the peptide
with the PTM has been detected by PTMsearch. The repetitive detection of a peptide
increases the chances of the peptide’s presence. This condition was set to 3 or more
occurrences to be required for accepted peptide detection. In general at least 2 of the
occurrences are expected to be made under the repetition of the same growth condition.
This condition does not ensure that peptide identification has been made correctly since
the same fragmentation pattern can be misidentified several times. However, it does
ensure that the stable fragmentation pattern has been detected multiple times, which
decreases the likelihood of detection of a noise spectrum.
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Results and Discussion

Post-translational modifications frequently serve as regulatory switches to protein
activities, they are capable of changing protein properties to influence transcription,
translation, ligand-binding interaction and many other cell processes, thus playing a
crucial part in the life of organisms and are extremely important to our understanding of
biological processes. While there have been many studies of post-translational
modifications in eukaryotic organisms and many interesting PTMs were discovered by a
variety of methods, there have not been as many attempts for the whole organism study
of PTMs in prokaryotes. Mass spectrometric instrumentation is uniquely qualified for
high-throughput PTM detection both because of its capability to measure the cell
proteome content and its ability to detect mass differences which generally accompany
post translational modifications. In this chapter, PTMsearch, a new algorithmic approach
for high-throughput PTM detection by bottom up mass spectrometry is introduced. In
addition, a whole proteome study of post-translational modifications in R. palustris is
performed with the use of available biological information.
R. palustris is a metabolically versatile prokaryotic organism it is expected to be
highly regulated on the proteomic level. The availability of R. palustris MS proteomic
data for a range of different growth conditions inspired an effort to attempt the detection
of a range of post-translational modifications in the organism. For the purpose of this
experiment R. palustris was grown under five different metabolic conditions. The growth
conditions included in the study were chemoheterotrophic, photoheterotrophic,
photoautotrophic, photoheterotrophic grown in benzoate medium and photoheterotrophic
nitrogen fixation; each of the conditions were analyzed at least twice to ensure the quality
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of data. In part, the project was driven by the hope to uncover some of the eukaryotic
post-translational modifications which could potentially be present in R. palustris and
have never previously been detected in prokaryotic organisms. As the result of the
computational analysis, 228 different peptides with post-translational modifications were
detected in 85 proteins (not all of the peptides were unique to one protein), however, all
of the computational data must be subjected to a set of experiments in order to be
confirmed. Thus, most of the results of this study are potential candidates for further
biological studies. However, so far two of the PTMs detected by this methodology have
been confirmed by a separate top down MS experiment.
A PTMLib database was built to incorporate all the protein sequences with
documented post-translational modifications presented in Garavelli’s RESID database.
Based on RESID, 223 different types of PTMs and 326 protein sequences were included
in the final PTMLib database. With the use of the PTMLib database, R. palustris
sequence database was pre-annotated for the possible 223 types of PTMs using BLAST
similarity search. All the R. palustris sequences with a BLAST’s E-value greater than 103

were included in the R. palustris PTM database which resulted in 287 proteins with 220

possible PTMs. The target sites were then annotated with the use of PROSITE software.
All of the collected MS data for R. palustris was then searched against the annotated R.
palustris database using new PTMsearch algorithm in order to detect the presence of
post-translational modifications.
PTMsearch is a generic database search algorithm based on SEQUEST’s Xcorrelation scoring scheme, coupled with filtering procedures designed to decrease the
amount of false positive identifications. As a result of analyzing the data from
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VerBerkmoes et al. 2005 with an exception of the stationary growth phase and lhaA
mutant growth phase, 228 unique peptides were identified as potential PTM carriers, with
29 distinct types of post translational modifications. As required by the filtering
procedure each of these peptides had to be detected at least 3 times during the analysis
before they were included in the final list of modifications. The detected posttranslational modifications include such PTMs as phospho-uridylylation, biotinyl, lipoyl,
acetyl, methyl, dehydroalanine, and carboethyl modifications and many others. The list
of all peptides with candidate PTMs can be found in the appendix 1, and the list of all the
proteins can be found in the appendix 2. However, as previously stated, even though,
these modifications can be considered biological sound in terms of their protein
localization, there are still many factors that could have caused incorrect identifications.
These detected peptides should, therefore, be experimentally verified, while they can now
be considered only as potential candidates for further studies rather than definite
identifications. The potential verifications can be done with the use of multiple enzyme
cleavage followed by LC-MS-MS (MacCoss, 2002), top down mass spectrometry, or
Edman degradation.
The spectra for two of the detected post translational modifications are presented
below. These modifications are uridylation and lipoylation. Uridylation was represented
in three tandem MS spectra under one growth condition, while lipoylation appears in
seven spectra and is found under a variety of different growth conditions. Both of these
modifications are not typically searched for in high-throughput proteomic data by typical
database search engines.
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An uridylation of P-II protein is an important regulatory signal modification
which serves as a regulator of the nitrogen metabolism in many organisms such as
Rhodospirillum rublum, Escherichia coli, Rhodopseudomonas palustris. Uridylation is a
reversible modification: under the conditions of nitrogen excess P-II proteins are
unmodified, while when the nitrogen concentration is low P-II proteins become
uridylated. The modified form of P-II is considered to be a signal of nitrogen starvation
(Atkinson, 1994). Thus, the presence of uridylated P-II protein are only expected during
nitrogen limiting conditions, while in all other growth conditions P-II protein are
expected to be unmodified.
The PTMLib derived from RESID database contains a sequence documented to
carry uridylation. The sequence blasted against R. palustris database yielded three
protein sequences: RPA2066 glnB nitrogen regulatory protein P-II 3360442:3360780
forward with E-value of 9e-37 (NREF entry number is NF01165177), RPA0272 glnK1
GlnK, nitrogen regulatory protein P-II 300253:300591 forward with E-value of 1e-34
(NREF entry number is NF01528520); RPA0274: glnK2 GlnK, nitrogen regulatory
protein P-II 302307:302645 forward with E-value of 2e-33 (NREF entry number is
NF01528171). The tandem MS spectrum of the uridylated version of peptide
GAEYAVSFLPK from RPA0274 protein is shown in the figure 4.5. The uridylation site
predicted by PROSITE for RPA0274 sequence was Y!RGAEY!, with tyrosine as the
potential modification binding site, “!” sign in the sequence denotes all the possible
modification sites. As it is shown in the figure 4.5, the detected modifications site is
EY!A. However, only one of the proteins was detected in the proteomic data, the peptide
with expected modification site appearing in both modified and unmodified form.
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Figure 4.5 The tandem MS spectrum of uridylated peptide. A representative spectrum of modified peptide GAEYAVSFLPK
is presented, showing the labeling of consecutive ‘b’ ions.
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As expected the modified version of the peptide appeared under the nitrogen limiting
conditions, while no unmodified peptide version was detected. No modified version of
the peptide was detected in other growth conditions.
One of the other detected post-translational modifications is lipoylation, which
mediates the transfer of electrons and activated acyl groups resulting from the
decarboxylation and oxidation of α-keto acids within the complexes. It is expected to be
present in the pyruvate dehydrogenase complex, which consists of three proteins: a
pyruvate decarboxylase, a dihydrolipoyl acetyltransacetylase, which contains α-lipoic
acid covalently bonded through amide linkage with lysine residue, and a dihydrolipoyl
dehydrogenase. (most of the information is adapted from Zubay, Biochemistry IIIrd
edition.)
The PTMLib contains four sequences homologous to lipoyl carrying proteins
documented in RESID database. The proteins are RPA2864 dihydrolipoamide
acetyltransferase 3241258:3242649 reverse MW:48330 (NF01529250), RPA3849
glycine cleavage system protein H 4348444:4349967 forward MW:12927,
(NF01528984), RPA0188 sucB dihydrolipoamide succinyl transferase 208123:209376
reverse MW:111339 (NF01530219), and RPA2866 pyruvate dehydrogenase E1 beta
subunit 3242963:3242958 reverse MW:11042 (NF01532208). However, the only protein
with lipoylated peptide detected was RPA2864, the peptide sequence being
SGDVIAEIETDK!ATMEVEAADEGTLAK, one of the tandem MS spectra for the
peptide is shown in the figure 4.6. The lipoylated sequence motif predicted by PROSITE
is: GDK!VK!SGDVIAEIETDK!ATMEVEAADEGTL, with lysine as specified binding
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Figure 4.6 The tandem MS spectrum of lipoylated peptide. A representative spectrum of
SGDVIAEIETDKATMEVEAADEGTLAK modified peptide is presented, showing the labeling of consecutive ‘y’ ions.
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site (all the lysines in the sequence are marked as possible modification sites). The
peptide was detected seven times under various growth conditions, as is expected from
the type of modification, since it’s presence is expected at all metabolic conditions.
PTMs are post-processing events that occur after protein translation and can
rarely be detected at the DNA sequence level. The detection of post-translational
modifications is very important for our understanding of biological processes as they
modulate the activity of many proteins during the lifetime of an organism. And while
they are notoriously difficult to analyze, their characterization can provide an immense
insight into biological function. While there are many studies of proteins and pathways
regulated by post-translational modifications they are generally performed on case by
case basis. These experiments are tremendously important for the advance of the
biological knowledge, however, they tend to be extremely slow and frequently must be
based upon already known facts. And while the goal of detecting and characterizing all
post-translational modifications in the cell is currently unattainable, it is desirable to be
able to elucidate the targets for studies of post-translational modifications with greater
efficiency as well as perform detections of already known PTMs.
Mass spectrometry is frequently used for detecting proteins in complex samples,
with its use it is possible to gain insight into the appearance of a mature protein which
can frequently be different from the expected based on the DNA sequence. It is a
technique that is well qualified for PTM analysis. While top down mass spectrometry
appears more desirable for analysis of post-translational modifications it is currently
limited by the technology limitations and is not generally used for high-throughput
analysis. The shotgun bottom up MS is a technique that is capable of characterizing
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proteins in complete proteomic samples. In this chapter, a new algorithmic method for
analysis of post-translational modifications by shotgun mass spectrometry was presented
and applied to the detection of post-translational modifications in R. palustris. While
prokaryotic organisms are rarely studied for PTMs, it was expected that an organism with
such metabolic variability might be highly regulated on the PTM level. However, while
shotgun mass spectrometry can be used to detect post-translational modifications, further
experiments must be considered to verify the made identifications. With the use of the
new algorithm for PTM detection, we have uncovered a number of peptides that are
likely to be post-translationally modified. There are several experiments that can be used
for verification of these findings. One strategy that could be applied to the PTM presence
verification is multiple digest strategy. It involves digesting the sample with different
types of enzymes and analyzing them by bottom up MS. The presence of the PTM in
several overlapping peptides from different digests is a strong indication for the correct
identification. The other strategies can involve isolating the proteins of interest under
the specified conditions and analyzing them one by one. In this case, the purified
proteins can be subjected either to Edman degradation to determine the presence of the
post-translational modification or they be analyzed with top down MS using ES-FT-ICR,
which can measure the accurate mass of the intact protein, providing the information on
the mass shift. To be conservative, an extensive analysis is necessary to confirm the
presence of a post-translational modification after it has been detected by bottom up MS
method. However, the shotgun bottom up PTM detection can be used to produce
candidate proteins for the thorough analysis providing new and interesting avenues in the
research of post-translational modifications.
99

Chapter 5
Computational Simulations for Mass Spectrometry-Based Identification of
Biological Agents

Some of the data presented below has been presented as Razumovskaya J., Fridman T.,
Day R., Borziak A., VerBerkmoes N., Hettich R., Uberbacher E., Gorin A., poster
presentation at ASMS 2004
Introduction

Current political events and acts of terrorism have elevated the demand for
suitable instrumentation to detect and identify potentially threatening biological agents,
such as bacteria, viruses, toxins and chemical agents. This heightened demand for a
robust instrument with the capability to simultaneously identify all possible threats within
a narrow timeframe exceeds current technology. In order to develop novel
instrumentation with such capabilities, it is necessary to probe the threshold of current
instrumentation using computational simulations. This chapter describes a computational
simulation of organism detection in a complex biological background using top down and
bottom up mass spectrometry. The focus of this chapter is to explore the differences
between these two approaches and the acceptable instrumental parameters for each of the
methods.
Detection of an organism in a complex biological sample is a two-sided problem
of sensitivity and specificity of detection. From the side of sensitivity, it is necessary to
be able to detect the organism of interest, however, it is also essential to be sufficiently
specific to recognize the absence of an organism in the complex mixture. Both
sensitivity and specificity of a method are equally important. Without high sensitivity
many biological agents may not be detected, while without high specificity, there will be
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a very high rate of incorrect detection, rendering the method similarly ineffectual.
Sensitivity of organism detection by mass spectrometry is significantly dependent upon
the differences between the concentrations of the organism of interest and the background
as mass spectrometry measures protein abundance. Specificity is only affected by the
measurements of the proteins present in the sample, focusing on whether background
proteins could be erroneously accepted as the evidence of the presence of the organism of
interest. In the presented theoretical simulations, the data is fully computer generated, the
real experimental conditions are only approximated and noise potentially present in the
spectra is ignored. Thus, the sensitivity is not in question – a protein from the organism
in question can always be detected. However, there is an uncertainty as to the specificity
of the method: whether a protein from the background could be misidentified as
belonging to the organism of interest. Therefore, in this chapter, we evaluate only the
specificity of detection of an organism of interest in a complex background by computer
simulations.
Current methods of organism characterization

Basic PCR detection method: Polymerase chain reaction (PCR) based organism
detection is an old and well established technique. It is based on the concept of DNA
hybridization – a set of oligonucleotide primers from a particular organism is added to the
DNA sample, if the primers complementary to the DNA in the sample, they hybridize,
and the organism is detected. If there is no hybridization, it is assumed that the
organism’s DNA is not present in the sample.
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Possible downfalls/problems:
1. DNA can be changed through genetic manipulations while it is significantly more
difficult to alter proteins.
2. Have to be able to make template DNA from the sample in field in order to detect
any new organisms.
3. All the components of PCR must be made stable under long periods of time.
Antibody based detection method: Antibodies are developed to recognize particular
proteins. When the proteins are present in the sample, the antibodies will recognize them
and give out a signal.
Possible downfalls/problems:
1. The development of new antibodies is difficult and takes a long time. This
constraint, therefore, limits it’s usefulness for the detection of new organisms.
2. It is difficult to select a combination of proteins which will be specific only to one
specific organism strain.
3. The antibodies may not be very specific to an organism in the truly complex
background. When more organisms are introduced into the sample the chances
that another organism possesses the protein for which the antibody was designed
increases.
Mass spectrometry: Mass spectrometry is a technique uniquely qualified to quickly
characterize a complex proteomic mixture by measuring the masses and fragmentation
patterns of the proteins in the mixture. This capability can be used for detection of one or
more organisms within a large proteomic sample. Frequently mass spectrometry is used
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to characterize an organism’s proteomic content, therefore it can be proposed that it also
possible to characterize protein content of multiple organisms.
Top down versus bottom up

In this chapter we discuss two main mass spectrometric techniques used for
protein characterization: the top down and bottom up methods as the techniques of
organism detection. The top down method is used to directly characterize protein content
and the bottom up characterizes the protein content by the analysis of protein pieces -peptides. The top down method involves measuring the m/z ratios of intact proteins,
while the bottom up method involves proteolytic digestion, cutting the intact proteins into
shorter amino acid stretches (peptides) with one or more proteases (such as trypsin,
pepsin, GLU-C, etc) and measuring m/z ratios of the resulting peptides. Either of these
methods can be coupled with tandem MS analysis, providing the sequence information
(fingerprint) for the analyzed protein.
The advantages of using top down analysis for the organism detection lie in the
potential speed of measurement and the reduced complexity of the mixture leading to the
reduced complexity in the identification process. The potential speed of measurement is
due to the fact that top down technique does not require protein digestion period -protein masses are measured intact. The reasons for reduced complexity of the
identification (as well as the speed of analysis) are a) intact protein masses are generally
more distinctive then the peptide masses and b) each protein in the organism corresponds
to a single measurement (assuming there is only one form of every protein, and not taking
into account the isotopic packet). The disadvantages of this technique involve a) not
fully developed instrumentation (expensive and not designed for routine operation
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devises), b) difficulty of protein mixture separation by liquid chromatography, c)
difficulty in deconvoluting the intact protein spectra, d) difficulty in performing tandem
MS on intact proteins cause incomplete tandem MS patterns.
For the past decade bottom up has been the main method for high-throughput
proteomic experiments, instrumentation becoming well developed, robust and routine to
operate. Another advantage of bottom up technology is that it provides nearly complete
peptide tandem MS fragmentation. The disadvantages of bottom up are the increased
time of measurement and the identification complexity. The increased time of
measurement is due to the time spent performing the proteolytic digestion which can
range from a few hours to an overnight digest (which is a common practice during
proteomic experiments). The increase in the identification complexity is caused by the
amount of peptides to be interpreted, as each protein can correspond to 20 peptides, in
most cases any single peptide identification being inconclusive as to the presence of the
parent protein.
The described computational simulation is designed for two purposes: a) to
examine the performance of the two techniques for detection of a potential biological
agent in an environmental sample and b) to evaluate the instrumental parameters which
will be necessary for the task for each of the techniques. The performances of the top
down and bottom up methods are measured by a series of computational studies which
not only make it possible to easily create a controlled experiment, they also allow for
straightforward way to vary the instrumental parameters. Even though computational
simulations lack many elements of real life situations such as noise, concentration
detection limits, multiple parent ions in the fingerprint pattern and others it can serve as
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an indication of best case scenarios for these experiments. Using the guidelines shown
by the simulation, it will be possible to select the best experiments to pursue the strategies
for organism detection. The simulation involves choosing an organism of interest which
will represent the biological agent and a realistic organism background which can
approximate the complexity of an environmental sample. Then the specificity of
organism of interest detection is tested by both top down and bottom up methods with
varying instrumental parameters. The specificity performances of the two methods can
then be compared and the best instrument and experiment can be described.
Materials and Methods
Simulation design
Simulation of biological agent

In order to simulate the detection problem, an organism of interest was selected to
represent a biological agent and the complex organism background to represent an
environmental sample.
The organism of interest chosen for detection is the widely studied gram negative
prokaryotic organism Escherichia coli (E. coli) K-12. One of the best studied model
organisms in molecular biology and biochemical genetics, E. coli K-12 was one of the
earliest candidates for full genome sequencing, its complete genome sequence published
in 1997 (Blattner, 1997). E. coli K-12 is a generally harmless bacteria frequently found
in mammalian intestinal tracks. E. coli genome consists of 4237 number of genes, each
of which could potentially form a gene product that can be measured by mass
spectrometry. However, some of the predicted genes may not be coding for proteins and
not all of the proteins predicted by the genome database are expressed at all times in the
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proteome; in addition many of them are not in the abundance to be successfully detected
by mass spectrometry. In order to successfully detect an organism by mass spectrometry
all of these points must be taken into an account and only detectable proteins can be used
to represent the organism of interest. Thus, rather tha
n include all of the possible genes into the analysis, only a subset of E. coli
genome was selected to represent it as the target organism in the simulation. The
representative proteins were selected based on experiments, where the cell proteome was
repeatedly measured by mass spectrometry and analyzed by database searching
algorithms. The 376 proteins repeatedly detected in the proteome became the “signature
proteins” (from now will be referred to as “signature proteins”) for E. coli detection.
Simulation of environmental sample

The representation of environmental sample consists of twelve distinct organisms,
including prokaryotic and eukaryotic bacteria, plant and fungi (Figure 5.1). The
proteomes of some of the organisms are similar to E. coli proteome, increasing the
complexity of the analysis. Many of the organisms are commonly found in soil and water
samples. The twelve organisms are expected to be a reasonable representation of the
complexity of an environmental sample. Here are short descriptions of the selected
organisms. Bacillus anthracis is gram positive spore forming prokaryotic organism
widely distributed in nature and a potential biological weapon, Deinococcus radiodurans
is a gram positive prokaryote and the most radiation resistant organism known,
Burkholderia xenovorans formally known as fungorium and is a gram negative organism
widely found in soils, Geobacter metallireducens is a gram negative microorganism
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Figure 5.1 Component organisms used in the simulation.
The representation of background sample consisting of in total 12 organisms and the
target organism (Escherichia coli)
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capable of reducing metals generally found in sedimentary environments, Nitrosomonas
europaea is a gram negative ammonium oxidizing bacteria commonly found in the soil,
and Pseudomonas aeruginosa, is a gram negative opportunistic pathogen widely
distributed in soil and water. The two strains of Yersinia pestis CO92 and KIM are gram
negative organisms known to cause plague, commonly found in nature, Arabidopsis
thaliana is the first plant to be completely sequenced, Saccaharomyces cerevisiae is a
eukaryotic fungus and is widely utilized by humans in food production industry,
Rhodopseudomonas palustris is a gram negative prokaryote commonly found in
sedimentary environments and Shewanella oneidensis is a gram negative prokaryotic
organism found in water and soil. The majority of the information about the organisms
was adapted from Margulis and Scwartz’s “Five Kingdoms”, 2001. Together, the
proteomes of these twelve organisms represent the environmental background for this
simulation. The environmental background protein mixture consists of 83,777 proteins,
which will later be referred to as “background proteins”.
In order to assure that the simulation is realistic we compared the mass
distributions of the 376 “signature proteins” found in E. coli to the 83,777 “background
proteins” as shown in the figure 5.2. The mass distribution of the “signature proteins” is
similar to the mass distribution of “background proteins”; all of the masses of “signature
proteins” lay in the same region as the “background protein” masses, which simulates the
worst case scenario since none of the “signature protein” masses are significantly
different from the “background protein” masses. The inset shows an enlarged view of
mass distribution of E. coli proteins in the window of 10,000 Da. The number of E. coli
proteins in the window is small comparing to the number of the background proteins.
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Figure 5.2 Protein mass distributions for the background and E. coli proteins. Illustrates the mass distributions of
background proteins and the E. coli “signature proteins”. The inset demonstrates the blown up area of “signature proteins” in the
mass range of 0 – 10,000 Da. Each “signature protein” is found in a bin with about 400 times more background proteins.
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Scoring schemes

The second step to performing the study was to formulate a feasible scoring
system for protein and peptide identifications and organism detection. The scoring
schemes consist of following two parts: a) score for tandem MS spectra, which are used
to measure similarity between two tandem MS spectra and b) score for the organism
detection, which is used to determine presence or absence of an organism within the
mixture.
Fingerprint scoring schemes

The tandem MS scoring scheme for both top down and bottom up data analysis
was adapted from the widely used mass spectrometry data interpretation software
package, SEQUEST. It is a general cross-correlation score used for spectral comparison.
As described in the original SEQUEST paper (Eng, 1994), the cross-correlation function
between two spectra can be calculated using following formula:
F (τ ) = ∑i =1 x[i ] ∗ y[i + τ ] , where x[i] represents a spectrum from E. coli “signature
n

proteins”, y[i] represents a spectrum from the background protein and τ is the
displacement value by which the mass index is offset. The cross-correlation then is
F (0) −
computed as follows: cross − correlation =

10

∑ F (i)

i =−10

20

. As shown in the formula, in

this study, the displacement τ is varied in an interval of [-10;10] in increments of 1. If
two spectra are the same, the cross-correlation function should be maximized at the
displacement 0, thus the comparison between the F(0) and average of the displacements
in the [-10;10] interval reflects the similarity between the two spectra. The cross
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correlation function can then be normalized by dividing by the best cross-correlation
achievable: auto-correlation. Then the final normalized cross-correlation formula applied
in the simulation can be described as follows:
10

Score( pattern1, pattern 2) =

F ( 0) −

∑ F (i)

i = −10

20
, where pattern1 stands a spectrum
Score( pattern1, pattern1)

(fingerprint pattern) of a “signature protein” and pattern2 stands for the spectrum
(fingerprint) of a background protein.
Organism scoring schemes

The score used for the assessment of organism detection (later referred to as
OrganismScore) was developed to reflect the likelihood of organism’s presence, based on
the detection of “signature proteins” found in the mixture. Though it appears that the
occurrence of each of the “signature proteins” in the mixture should increase the
probability for the presence of an organism in the sample, it cannot be expected that a) all
of the “signature proteins” will be reliably detected and b) all of the “signature proteins”
are unique to the organism of interest and have no duplicates within the background.
Therefore, a concept of OrganismScore was introduced in order to evaluate the reliability
of organism detection. The OrganismScore should involve two factors for each
“signature protein”: factor1, how reliably the protein was detected and factor2 how
unique the protein is to the organism of interest versus the background mixture proteins.
The reliability of protein detection, factor1, can be estimated by any scoring
scheme used for spectral comparison (comparison between the fingerprints of the
“signature protein” and the measured fingerprint) such as cross-correlation used in this
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simulation. However, since this simulation does not involve modeling noise, the crosscorrelation score for a perfect match always results in a score of 1 (where 1 is the highest
possible score). Therefore, for this simulation purposes, the reliability term of protein
detection has been made binary – a protein is either detected (factor1 is assigned to 1) or
it is not (factor1 is assigned to 0). In further studies it is possible to model noise and
improve detection by assigning weights to factor1.
The assessment of protein’s uniqueness to the organism of interest in a
background mixture is factor2 for the OrganismScore. In case of a particular “signature
protein” being present only in an organism of interest, and not in the background mixture,
the protein would be unique to the organism of interest (here, E. coli) and thus, a reliable
detection of such protein would lead to the detection of the organism. On another hand,
if several “signature proteins” could also be found in the organisms present in the
background sample, their detection would not mean the presence of the organism of
interest. Thus, knowledge whether “signature proteins” are unique to the organism of
interest is very important, however, since the identity of organisms present in the real
samples is unknown, we would have to assess the likelihood that the protein is unique to
only one organism in nature.
A protein with a distinctive amino acid sequence (the protein mass can coincide
with masses of other proteins but their sequences must be different) can be considered
unique, and ideally can be identified by mass spectrometry by a combination of mass and
fingerprint information. A presence of a homologous protein with a 98% sequence
similarity (a slightly different sequence) in a background mixture generally won’t lead to
an incorrect identification with top down mass spectrometry due to the differences in
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overall protein masses. However, since not all the organisms are yet sequenced and our
knowledge about genes and proteins is still limited it is not a simple task to assess the
uniqueness of a protein in nature. In general, it is expected that protein sequence is
conserved if it is crucially important for its functionality. The answer of protein sequence
conservation lies in observing its family members – the homologous proteins from other
organisms. It is frequently observed that functionally important amino acids are
conserved within sequences in a protein family, while parts of a sequence may differ; the
more amino acids are functionally important the more sequence is shared between
homologous proteins. Protein family based profiles are used to assess the uniqueness of a
protein. Using BLAST searches against nr (All non-redundant GenBank CDS
translations, RefSeq Proteins, PDB, SwissProt, PIR and PRF) database available from
NCBI, all of the homologous proteins from different sequenced organisms present in the
mentioned databases can be found, it is then possible to calculate the position dependent
frequency of amino acid conservation (how frequently an amino acid in a particular
position is conserved within the family); an example of such matrix is shown in the figure
5.3. It is then possible to compute the likelihood that the exact copy of the protein can be
present in another organism using the amino acid conservation frequency information by
combining the conservation frequencies of amino acids in each position. The probability
M

is computed in the form of factor 2(i ) = 1 − ∏ FM (ak , k ) , where M is number of amino
k =1

acids present in the ith protein, FM is the family profile frequency matrix, and FM(ak,k)
stands for frequency of conservation of amino acid a, in kth position in the sequence. As
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Figure 5.3 Frequency matrix based on family profile information. Shows an example of family based profile frequency
matrix, where the vertical sequence represents the protein sequence and the horizontal sequence represents the twenty amino
acids. Each position in the matrix symbolizes the frequency of an amino acid substitution in the sequence based on the protein
family.
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it can be noticed, multiplication of numbers below 1 over a large M would produce a 0,
therefore, in real calculations log scales were employed to compute factor2.
For the purposes of the simulation, factor1, the presence of a protein in the
mixture, is defined in binary terms dependant on the accepted cross-correlation score
cutoff (given a score cutoff, all the proteins with a cross-correlation lower than the cutoff
are considered absent: factor1 = 0, and all the proteins with a cross-correlation above the
cutoff are considered present: factor1 = 1). The factor2, protein uniqueness scores, are
normalized, so that the sum of all factor2 scores for the “signature proteins” is equal to 1

(∑

N
i =1

)

factor 2(i ) = 1 , where N stands for the number of “signature proteins” in the

organism of interest (here, 376). The definition of OrganismScore is then the normalized
sum of the multiplied protein presence and protein uniqueness over all the “signature
proteins” of an organism: OrganismScore = ∑i =1 factor1(i ) ∗ factor 2(i ) , where if all of
N

the “signature proteins” are present in the sample, OrganismScore is 1, and each of the
present proteins makes a contribution to the OrganismScore according to its likelihood of
uniqueness in nature, factor2. Since detection of all “signature proteins” in the sample
yields an OrganismScore of 1, it is easy to compare the probability of organism detection
between different samples and different organisms of interest where background and
“signature proteins” are different.
Results and Discussion

The described simulation involved exploring the efficiency of organism detection
by top down and bottom up mass spectrometry approaches with varying instrumental
parameters. Both approaches were performed in two modes: MS mode and fingerprint
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mode. MS mode refers to using only MS information (measurement of protein or peptide
mass), and fingerprint mode refers to using both MS and MS/MS information (using
measurement of mass and sequence fingerprint).
The MS mode was used to determine the fractions of “signature” proteins and
peptides which could be separated from the “background” proteins and peptides based on
their mass alone for varying accuracy measurements. The accuracy measurements for the
MS mode top down experiment were varied in the interval of 0 to ±20 Da, with an
incremental step of ±1 Da; for the bottom up experiment, the accuracy measurements
were varied between 0 and ±5 Da, with ±0.001 Da and ±0.1 Da in the range of 0 to 1 and
an incremental step of ±1 Da in the range of 1 to 5.
The fingerprint mode was used to evaluate the specificity of E. coli detection in a
background of 12 other organisms. The top down method simulations were arranged to
explore varying parameters for the measurement accuracy and the fragmentation
efficiency. Since fragmentation of intact proteins is not easily achieved and is generally
very limited, the fragmentation efficiency for top down experiment was explored. The
results shown for the top down method are for the measurement accuracy of 20 Da, the
fragmentation efficiencies are varied between 1 – 150 fragments per protein. In case of
bottom up experiments, the peptide fragmentation is significantly more efficient than the
protein fragmentation and the bottom up data interpretation programs, such as
SEQUEST, assume complete peptide fragmentation. The bottom up method simulations
were performed with ±3 Da measurement accuracy, while the fragmentation efficiency
for peptides is considered to be complete.
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Top down MS mode

The MS mode for top down simulation shows the dependency between the
fraction of unique “signature protein” masses and the measurement uncertainty. In order
to establish the fraction of unique “signature protein” masses, mass of each “signature
protein” was computed and compared to the computed masses of the proteins from the
“background mixture” with varying measurement uncertainty in the interval of 0 to ±20
Da. Measurement uncertainty applies to the delta error allowed for the matching between
observed and expected masses. As expected, the higher is the measurement uncertainty
(higher measurement accuracy), the less there are “signature proteins” with unique
masses. At an extremely low measurement uncertainty of 10-4Da, the fraction of unique
protein masses approaches 1 as shown in the figure 5.4. Most of the proteins possess
unique mass at such accurate mass measurement, using an instrument with such accuracy
and resolution, it might be possible to perform specific organism detection in a top down
MS mode unless there are present background proteins with the same amino acid
composition and different sequence. However, the fraction of unique proteins is then
sharply reduced to 0.21 at the measurement uncertainty of ±1 Da, decreasing even further
to 0.03 at the measurement uncertainty of ±10 Da. The top down MS mode can only be
used for organism detection when the instrumental accuracy and resolution are extremely
high, rendering measurement uncertainty to being almost negligible.
Bottom up MS mode

A similar analysis to measure the specificity of detection was performed for
bottom up MS mode as previously mentioned for the top down MS mode. In order to
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Figure 5.4 Unique “signature protein” masses as comparing to the background set as a function of measurement error.
The plot of intact protein masses that are unique to the E. coli “signature proteins” at varying measurement uncertainties.
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perform bottom up simulation, the “signature proteins” firstly have been in silico digested
by trypsin to produce “signature peptides”. Trypsin digest leads to cleavages along the
peptide backbone after Lysine (K) and Arginine (R) residues. During an experiment, due
to insufficient digest time, incomplete peptide denaturation and other causes trypsin
digest is often incomplete leaving peptides with internal K and R residues. In an attempt
to model a realistic tryptic digest, up to four missed cleavages has been allowed in the in
silico digest process (the accepted settings for bottom up data interpretation programs).
The digestion produced 70,000 “signature peptides” (only peptides with different
sequences were considered), and 125 million of unique background peptides. The MS
mode for bottom up simulation shows significantly reduced number of unique masses for
the “signature peptides”. As illustrated in the figure 5.5, the fraction of unique peptide
masses at the measurement uncertainty of 10-4Da is less than 0.24, while at the
measurement uncertainty of ±0.01 Da, the fraction of unique peptides is 0.08. It would
be impossible to specifically detect E. coli in this background based exclusively on the
peptide masses with measurement uncertainty higher than 10-4Da and even then, the
number of non-unique peptides if very high. In this simulation, MS mode for bottom up
does not appear to be a successful approach for a specific organism detection.
Top down fingerprint mode

The fingerprint mode for top down simulation shows the specificity of E. coli
detection in the complex background sample under varying measurement parameters.
The first parameter is previously examined measurement uncertainty and the second is
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Figure 5.5 Unique “signature peptide” masses as comparing to the background set as a function of measurement error.
The plot of peptide masses unique to the E. coli “signature peptides” at varying measurement uncertainties.
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the tandem MS fragmentation efficiency. The experiments involving measurement
uncertainty have been addressed in the MS mode section, showing the impact of delta
error on the protein/peptide detection accuracy. The primary focus of this part of the
experiment is to observe the changes in detection specificity as a function of
fragmentation efficiency. The fragmentation efficiency refers to the capacity of the
instrument to break a biological molecule into smaller fragments creating its fingerprint
pattern (sequence information). As previously mentioned, the fragmentation of intact
proteins is frequently incomplete, providing only a few fragments while the core of the
protein often remains whole. The greater is the amount of fragmentation, the more
information is contained in the fingerprint which then provides a more specific
identification.
As noted above in the top down MS mode section, measurement uncertainty
applies to the delta error allowed in matching between observed and expected masses. In
the fingerprint mode it was fixed at the reasonable values, when the parent mass alone
can not be used as a detection factor. In case of top down experiment, it is expected that
increased measurement error will not greatly affect the resulting specificity since at ±10
Da error a large increase in measurement error causes comparably small changes in the
number of matching background proteins. The range of 0-1 Da of measurement
uncertainty where the parent mass for top down experiment can be used for protein
detection was not considered in this study as an unrealistic measurement constraint
creating a greater background dependency (more proteins with similar masses could be
found within a different background).
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In order to establish fragmentation efficiency necessary for confident and specific
organism detection, the detection of E. coli proteins was attempted in the background
mixture with varying fragmentation efficiencies for the background proteins. As
previously noted, greater fragmentation efficiency (more resulting fragments) provides a
more informative fingerprint – the greater the number of fragments the lower is the
chance that protein will be identified incorrectly. Separate simulations were performed
for eighteen fragmentation efficiencies. Fragmentation efficiency was modeled by
creating incomplete fingerprints of length N for each of the background proteins, where N
stands for the number of fragments allowed per protein and remains the same for all
proteins in a given simulation. The procedure involves creating all the fragment ions
possible for a protein (for an average protein of length 300 amino acids, the number of all
expected fragments is ~600), and randomly selecting N of them to create a fingerprint.
Each protein fingerprint from E. coli “signature proteins” was compared using crosscorrelation to the incomplete fingerprints of all of the background proteins that match the
“signature protein” by parent mass within the delta mass window. The plot of “signature
protein’s” scores for a fragmentation efficiency of N = 10 is shown in the Figure 5.6. The
black line (“second hit”) representing the highest cross-correlation score from the
background protein as comparing to each single “signature protein”. In the absence of
noise, the cross correlation of “signature protein’s” fingerprint to itself would produce a
score of 1. The red line (“average hit”) shows the average of cross-correlation scores for
all the background proteins matching each single “signature protein”. Only in one case a
best score for a background protein achieves a cross correlation of 1 (full score for
“signature protein”), all other background protein top scores ranging from 0.7 to 0; the
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Figure 5.6 Protein detection with fragmentation efficiency N = 10.
Difference in scores for “signature proteins” fragmentation patterns as comparing to the best and average matches in the
background. The “x” axis represents the number of a protein in the “signature” set from 0 to 376 and “y” axis represents
normalized cross correlation score.
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average of top background protein scores are 0.38. The average scores of all background
proteins show how far the top background protein score is from the average. In this
figure, the average of cross correlation of background proteins to the “signature proteins”
is shown to be 0.
The specificity of the method in this case can be measured by the percentage of
incorrect identifications as a function of cross-correlation score cutoff. Score cutoffs are
set in order to make a decision whether a protein is detected. It is not expected to have
“signature proteins” in the background sample, therefore all of the proteins “detected” in
this simulation are in fact incorrect identifications, which can lead to unspecific detection
of an organism of interest. The specificity of protein detection for the fragmentation
efficiency of N = 10 is shown on the Figure 5.7. At the cross-correlation score cutoff of
0.4, 21.8% of “signature proteins” are detected in the background sample. It is sharply
reduced with increasing score, with cross-correlation cutoff of 0.5, less then 10% of
incorrect identifications remain, and at score cutoff of 0.9, there is only one “signature
protein” that is still detected in the background mixture. Upon examination, it was found
that one of the background proteins has an identical amino acid sequence as the
“signature protein”, making it impossible to differentiate between them. Therefore, at
least one E. coli “signature protein” will always be incorrectly “detected” in this
background mixture.
In the eighteen top down organism detection simulations, the fragmentation
efficiency ranged from N = 10 to N = 150 fragments with an increment of 10 fragments;
in the window 0-10, additional points of N = 1 and N = 5 fragments were included. The
dependency of “signature protein” detection as a function of
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Figure 5.7 Specificity of protein detection.
Percent of background proteins incorrectly matching to E. coli “signature proteins” as a function of the cross correlation score
cutoff.
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fragmentation efficiency for the range of N = [0, 150], is shown in figure 5.8. The black
line shows the average of cross-correlation top scores between all the “signature proteins”
and the corresponding background proteins for each N. The red line refers to the average
of the mean cross-correlation scores of all the “signature proteins” to the background
proteins. As expected, Figure 5.8 shows that there is a relationship between the
fragmentation efficiency (N) and the specificity of protein detection: as the fragmentation
efficiency increases, the correlation between the background proteins and the “signature
proteins” decreases, improving the specificity of the detection. While the average top
background score for N = 1 was 0.8, the score for N = 20 is 0.23, for N = 60 is 0.18 and
for the greatest considered fragmentation efficiency of N = 150 is 0.16. The lower is the
score, the less is the likelihood of incorrect detection of a “signature protein” in the
background sample, and the greater is the noise tolerance in the detection scheme.
Bottom up fingerprint mode

The fragmentation efficiency that is considered a substantial factor for protein
identification in the top down experiments does not play a significant part in the bottom
up experiments. Smaller peptides tend to fragment more efficiently than the large
proteins, in general providing good fragmentation coverage. In this simulation, therefore,
the fragmentation efficiency of peptides was considered as full fragmentation – all of the
possible background peptide fragments were included in the fingerprint. The
measurement uncertainty used for the bottom up simulations was accepted as the ±3 Da.
As previously shown in the MS mode section, the peptide mass can not be used for
reliable peptide detection, the delta error of ±3 Da yielding to 3 peptides unique to the set
of “signature peptides” in the background peptide mixture. In addition, ±3 Da is
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Figure 5.8 Dependency of correct detection on the number of fingerprint fragments. The greater is the fragmentation
efficiency, the higher is the specificity of organism detection.
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considered one of the accepted delta error settings during real database search procedures
and expected to be a reasonable error for peptide parent mass matching.
The results of the peptide detection simulation in terms of top and average
background peptide cross-correlation scores are shown in the figure 5.9. The peptides are
arranged by masses, as it is shown, the smaller are the peptide (the lower is the parent
mass) the higher are the scores of background peptide as comparing to the “signature
peptides”. In fact, there are many background peptides, for which cross-correlation
scores are higher than 0.9, approaching 1. Such background peptides would likely
produce erroneous peptide detection when the parent protein is not present in the
background sample. It can be seen that at higher peptide masses the cross-correlation
scores between the “signature peptides” and background peptides are significantly lower
than at the lower masses. The reason behind this phenomenon can be easily explained, a
short amino acid sequence is generally less specific than the longer one: the peptides
with lower masses have a short amino acid sequence since there is a direct relationship
between the mass and length of a peptide and a number of possible combinations of
amino acids in a short sequence with matching parent mass is significantly smaller that in
the long one, allowing for a greater chance of the same sequence occurring in both
“signature peptides” and the background samples. The “signature peptides” with mass
greater than 10,000 Da are as unique as the “signature proteins”. Unfortunately, there are
limitations to mass detection with the instrument used to perform the bottom up analysis,
as this study is focused on ion trap MS which can detect a m/z range of 200-2000 Da.
Even though the instrument detects mass to charge ratio (increasing the scope of the mass
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Figure 5.9 Peptide detection. Difference in scores for “signature peptides” fragmentation patterns as comparing to the best and
average matches in the background. The “x” axis represents peptide mass and “y” axis represents normalized cross correlation
score. With increasing mass, the cross correlation scores decrease (the specificity increases).
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detection) there is no hope to detect peptides with very large masses. Therefore, for the
purpose of this simulation, only peptides with masses less than or equal than 6,000 Da
were used for further analysis. This mass cutoff has been judged extremely generous,
since on average the peptides detected with the technology are of 2,000 – 4,000 Da.
The specificity of cross-correlation for the bottom up method for peptides with mass less
than 6,000 Da is shown in figure 5.10 as the percent of incorrect peptide detection as a
function of the cross-correlation score cutoff. At the cross-correlation score cutoff of 0.4,
57% of “signature peptides” have been detected in the background mixture incorrectly,
while with the score cutoff of 0.9, 19% of “signature peptides” are incorrectly detected.
The percentage of incorrect identifications in bottom up analysis at a score cutoff of 0.4 is
incomparable to that of top down (21.8%). Additionally, in bottom up simulation, while
the number of incorrect identifications is reduced with increasing score cutoffs, it never
reaches less than 19%. It is expected that there is a large overlap between the “signature
peptides” and background peptides as can be seen in 5.9 (the background peptides which
received the cross correlation score of 1 have the same sequence as some of the
“signature peptides”). Because of this fact, at the highest score cutoffs there will still be
some background peptides with high enough scores to be identified the “signature
peptides”.
Top down and bottom up comparison

The specificity of detecting “signature proteins” is severely dependant on
fragmentation efficiency. Sparse fragmentation can frequently causes incorrect or
inconclusive identifications since any of the fragments in one spectrum can match
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Figure 5.10 Specificity of peptide detection. Percent of background peptides matching to incorrectly to “signature peptides”
with masses less than or equal to 6,000 Da as a function of the cross correlation score cutoff.

131

another spectrum by accident. The likelihood of correct identification increases with the
number of matches while only when all major fragments between two spectra match (and
none of the major fragments are mismatched), the identification can truly be considered
confident. In case of top down tandem MS, the complete fragmentation cannot be
expected, while the bottom up mass spectrometry is generally expected to provide
complete fragmentation. To explore the advantages and disadvantages of the two
methods a comparison must be made in terms of their specificity of protein detection.
Since the fragmentation efficiency is a significant factor in the top down mass
spectrometry, several fragmentation efficiencies must be considered for the comparison.
As shown in the figure 5.11, the percent of incorrect identifications was compared
between bottom up method (complete fragmentation efficiency) and top down method
with three different fragmentation efficiencies.
The top down fragmentation efficiencies include the worst case scenario, where
fragmentation efficiency is very low: N = 5, the mid-case scenario, where the
fragmentation efficiency is somewhat efficient: N = 20, and the best case scenario, where
the fragmentation is closest to being complete (in the scope of this experiment): N = 150,
where, as previously mentioned, N stands for the number of allowed fragments per
protein. There is a significant difference between the number of incorrect identifications
in the three scenarios at the lower score cutoffs – the best case scenario performs
dramatically better than both worst and mid-case up to cutoff of 0.3, at fragmentation of
N = 150 when at the cutoff of 0.2, the number of incorrect identifications is already
nearly negligible (around 5%), the efficient fragmentation ensuring the efficiency of the
scoring. The mid-case fragmentation efficiency (N = 20) becomes comparable to the best
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Figure 5.11 Comparison between top down and bottom up detection specificity. Percent of incorrect identifications as a
function of cross correlation score cutoff. The results are shown for the bottom up simulation and for three fragmentation
efficiency scenarios of top down simulation. The fragmentation efficiencies include the best (N = 150), worst (N = 5) and mid (N
= 20) cases.
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case at the score of 0.4, getting closer and closer to the best case performance at the
increasing score cutoffs. The worst case scenario (N = 5) starts to show similar
performance to the other cases only after a score cutoff of 0.7, showing 3%, where as the
others two cases show 1% of incorrect identifications (in either case the percentage can
be considered negligible). However, though the worst case scenario is still capable of
showing a good performance at higher score cutoffs, the simulation contains no noise
modeling which would necessarily decrease the performance of all three scenarios, and in
likely case, would make the worst case scenario inadequate for protein identification.
As shown in the figure, bottom up’s performance in the simulation is significantly
inferior to top down in both the mid and the best case scenarios. Top down with
fragmentation efficiency of N = 20, at cross-correlation cutoff of 0.4 shows less than 10%
of incorrect identifications, while bottom up at the same cutoff shows 57%. The gap
between performances is not reduced at the higher score cutoffs. The bottom up method
is only comparable to the top down worst case scenario (N = 5). It shows a slightly
higher specificity (lower percent of incorrect identifications) than the worst case scenario
for top down method in the score cutoff region of 0.2 – 0.45, while performing slightly
lower for all the other score cutoffs. This result suggests that in case of this simulation,
bottom up technology could not be used to perform organism detection in the complex
background due to the great overlap between the “signature peptides” and the background
peptides. Even though, it is likely that bottom up method would be sensitive enough to
detect peptides it lacks the necessary specificity to be useful for real detection.
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OrganismScore

Specificity of protein detection plays a very important part in the detection of the
organism of interest. However, the detection of “signature proteins” in the background
mixture does not necessarily signify the presence of the organism represented by these
“signature proteins”. As the background sample becomes more complex (more
organisms and proteins are included in the sample) the chances that some of the
“signature proteins” appear in background organisms increase. While some of the
“signature proteins” can be fairly distinctive of the organism of interest, others can be
quite common in nature. Limiting the “signature proteins” to the proteins unique to the
organism of interest is very desirable, however there are two negative factors to reducing
the number of “signature proteins”. Firstly, the proteome content is known only for a
small fraction of existing organisms, making it difficult to differentiate between unique
and non-unique proteins and secondly it can greatly reduce the number of “signature
proteins” and where one unique protein cannot be used for positive organism detection, a
detection of a combination of non-unique proteins can be more conclusive.
OrganismScore scheme, described in the Scoring Schemes section, utilizes protein
uniqueness information as well as the number of detected proteins.
We estimate the uniqueness of each of the E. coli “signature protein” in nature using
positional frequency matrix created using family based profiles. Each of the “signature
proteins” received a weight coefficient (likelihood of a protein uniqueness ), which
determines its value to the organism detection. We then were able to calculate
OrganismScore for each protein cross-correlation score cutoff. The OrganismScores are
shown for four fragmentation efficiencies for top down mass spectrometry in Figure 5.12.
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Figure 5.12 Specificity of organism detection with OrganismScore. The top down organism detection with OrganismScore is
shown as a function of cross-correlation score cutoff. Top down fragmentation efficiencies include the best (N = 150), worst (N =
5) and two mid (N = 20, N = 70) cases.
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The fragmentation efficiencies shown are N = 5, 20, 70 and 150. The specificity
of E. coli detection in the background mixture using the OrganismScore shows
improvement from the simple count of number of proteins – for example, the protein
count for N = 5 fragmentation efficiency with score cutoff of 0.4 would produce a score
of 0.69 (69% of incorrect identifications as shown in the figure 5.11), while the
OrganismScore for the same setting produces a score of 0.62. The OrganismScore for
score cutoff of 0.8 for N = 20, N = 70 and N = 150 all show the same results of 0.001
(where as protein count would have shown 0.1) and for N = 5, shows 0.0062 (where as
protein count would have shown 0.2).
The described simulations of detecting E. coli in a complex background were
fashioned to approximate a real life situation of detecting a biological agent in an
environmental sample. The biological agent was represented by a set of 376 E. coli
“signature proteins”, which are readily detectable by mass spectrometry, while the
environmental sample was represented by a mixture of twelve organisms, containing
83,777 background proteins. The detections were performed using two mass
spectrometric approaches: the top down and bottom methods. The in-silico experiments
were focused upon establishing the specificity of detecting a biological agent in a
complex sample and exploring a set of instrumental parameters needed for such
detection.
The bottom up method is one of the most established methods for organism’s
characterization. The instrumentation and procedures are optimized and robust making it
a desirable approach for organism detection. However, there are a few expected
drawbacks to the bottom up methodology in terms of speed: a) bottom up method
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requires protein digestion before the analysis, to convert the proteins to shorter peptides,
b) the analysis itself is very complex due the great number of peptides present in the
mixture. In addition, the short peptides are generally not unique to a protein or an
organism, frequently making peptide detection not indicative of an organism’s presence.
Since the instrumentation is well established, the set of explored instrumental parameters
was limited. Here, the simulations only addressed the impact of parent mass accuracy
measurements on specificity of organism detection, the fragmentation efficiency was
considered complete basing on the fragmentation efficiency of the bottom up instruments.
The top down method is less established as a high throughput method, the
instrumentation and procedures being significantly less developed than that of bottom up
method. However, one of the goals of this simulation is to probe the thresholds of the
current instrumentation and to reach a conclusion which of these two methods is more
suited to solve the problem of biological agent detection. The current drawbacks of top
down methodology are mostly involved with analyzing proteins with mass spectrometry,
which is currently a difficult process in terms of protein separation, introducing proteins
into mass spectrometer and protein fragmentation. Some of these concerns were
addressed in the simulation with varying parameters in mass accuracy and fragmentation
efficiency. It was noted that changes in mass accuracy have a comparably insignificant
effect on the detection specificity after mass accuracy of ±5 Da for top down (Figure 5.4)
and ±1 Da for bottom up (Figure 5.5), therefore, the simulations were focused on
reasonable mass accuracy ranges instead of performing the simulations with all mass
accuracies.
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According to the in-silico simulations the top down methodology is inherently
better suited to the organism detection than the bottom up method. The comparisons of
specificity of E. coli detection by the two methods is shown in figure 5.11. The analysis
suggests that if top down fragmentation efficiency is greater than N = 5 (there are at least
5 fragment ions per protein) while the accuracy of protein mass measurement is no lower
than ±10 Da, it will be more specific in organism detection than the bottom up with
complete fragmentation efficiency and accuracy of peptide mass measurement of ±3 Da.
However, if there is no fragmentation in the top down method (only parent mass is
available) or the fragmentation efficiency is low (less than N = 5), top down method loses
its specificity as comparing to the bottom up. Even though, as illustrated in the Figure
5.4, when accurate parent mass is available (measurement accuracy is 10-4 Da) almost all
protein masses are unique to the E. coli “signature proteins”, the background sample
might become more complex rendering protein masses less specific. For the top down
experiment the preferred fragmentation efficiency based on this study is N = 20, a point,
where the specificity of detection does not change significantly with the increasing
number of fragments. It must also be noted that the protein fragmentation efficiency was
modeled by randomly choosing N ions from all the fragments produced from complete
protein fragmentation. In reality, the fragmentation is likely to follow different pattern,
and protein fingerprint might be less meaningful.
The last issue examined in the study was establishing a reasonable scoring scheme
for organism detection. OrganismScore was designed to provide the assessment of
likelihood of organism detection and allow for comparison between detections of
different organisms. OrganismScore is based upon the concept of uniqueness of a given
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protein in nature. The protein uniqueness is measured with the use of family based
profile of the protein. In essence, it is a measurement of amino acid conservation in the
protein sequence. Using a family based position dependent frequency matrix example of
such a matrix shown in the Figure 5.3, derived from the family based profile, it is
possible to compute the probability of all amino acids in the sequence remaining the same
in a different organisms. OrganismScore is normalized to 1, which allows for easy
assessment of organism detection as well as the comparison between OrganismScores for
different organisms in different environmental samples.
Mass spectrometry is an analytical tool that can detect proteomic signatures in
complex samples. As shown in this simulation, the complex background does not overly
interfere with the specificity of signature detection, while sensitivity of detection will
have to be explored by real experimental studies. One of the advantages of top down
mass spectrometry over the other techniques for organism detection is that the organism
does not have to be well characterized or sequenced before it can be detected by top
down mass spectrometry. The detection can be done based on a proteomic signature
pattern of unknown proteins as long as it has been measured once before. Indeed, top
down mass spectrometry can be used to detect changes in the environment, by separating
the signatures of organisms present in the background from any new organism signature
which appears in the sample. This detection is easily achievable by subtracting the
previously detected background signal from the measured spectrum of the environmental
sample leaving only the newly emerging signatures. If the new signatures are judged
harmless, they can be added to the background signal and won’t be considered in the new
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analysis. This approach can potentially make bio-organism signature detection
completely automatic and highly efficient.
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Modification Name

Peptide

MW of
PTM

# of
Occurrence
N6,N6,N6-trimethyl-Llysine_
O5-glycosyl-Lhydroxylysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
L-3-oxoalanine_
trans-2,3-cis-3,4-dihydroxyL-proline_
S-(L-isoglutamyl)-Lcysteine_
N-acetyl-L-methionine_
N6-1-carboxyethyl-Llysine_
N6-biotinyl-L-lysine_
N6-lipoyl-L-lysine_
N6-biotinyl-L-lysine_
N5-methyl-L-glutamine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-methionine_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
O4'-(phospho-5'-uridine)-Ltyrosine_
N5-methyl-L-glutamine_
L-serine_
N-acetyl-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
3'-(1'-L-histidyl)-Ltyrosine_
L-3-oxoalanine_
N6-1-carboxyethyl-Llysine_
N6-1-carboxyethyl-Llysine_
N-acetyl-L-methionine_
N6,N6,N6-trimethyl-Llysine_
N6-1-carboxyethyl-Llysine_

NYDPRAKIMQQVCHEVLAETGHHGDPLLK!
GK!QGPVGKPGPQGK

3

43.0548

12

VAPP!PPPQHAAPRMAPPPAPVRAAPPPPHVAPPR

3

178.0477+
31.9898

QLPGKDFSS!VLTNPSSADIHAVR
PSAPPTAAPAERPAAPP!PAAAPVRPPAPPAGEAPQ
R
TLSRYQ!LSDLGNERGAK

3
4

-2.0156
31.9898

5

-17.0265

AVFMTGHGGNEVIEVGDRPM!PQR
VNAVNPGMVVTEGVK!

8
4

42.0106
72.0211

6
3
12
3

226.0776
188.033
226.0776
14.0157

3

31.9898

LAM!AGFAAARALSTGFNDAPTKASR
REALDALAAK!LGER

3
3

42.0106
72.0211

PSAPPTAAPAERPAAPPPAAAPVRPPAPP!AGEAPQ
R
GAEY!IVDFLPK

5

31.9898

3

306.0253

VFTEAGEHIPVTVLKLGNCQ!VLGHRTK
AS!ADVALLK
FPEPYLAAFDGP!R
GLPPAPGVAARPGIP!SVAQPQPPGRPALGPGGPA
AAR
YVDY!PDAFAGWNLVSSIGSYISGFAVLVFLYGMT
LAFIRKER
ITRS!DEAIAAK
K!TIPAPAQALDAEANR

3
3
3
3

14.0157
87.032
42.0106
31.9898

3

-2.0156

4
4

-2.0156
72.0211

NAAEVDGAVAALK!

3

72.0211

RVVVTGM!GIVSSIGNNTQEVLASLHDAKSGISR
LSVEAGSVKMFEIADRIEAVMHESK!

5
3

42.0106
43.0548

GTDHKIGQLNPLK!R

3

72.0211

EAASARWMK!EADK
AAGAGWK!ASAGGAPSPQR
YPNDK!
VEEFRVSEDALLPVGAEIQADHFVVGQ!FVDVTGT
STGK
PAAPPP!AAAPVR
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trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-1-carboxyethyl-Llysine_
N,N-dimethyl-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N-acetylglycine_
O5-glycosyl-Lhydroxylysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-alanine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-proline_
N6-biotinyl-L-lysine_
omega-N-(ADP-ribosyl)-Larginine_
3-hydroxy-L-proline_
N6-lipoyl-L-lysine_
L-3-oxoalanine_
3-hydroxy-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-alanine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
3-hydroxy-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
dehydroalanine_
N5-methyl-L-glutamine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_

AAPPPPHVAPPRPPAPPRAAPPP!R

3

31.9898

VAPPPP!PQHAAPRMAPPPAPVRAAPPPPHVAPPR

4

31.9898

EGAAVVVNDLGGPRDGSGSDAGMAQQVVDAIK!

3

72.0211

GIGVEIALK!LAAEGAAVAVNYASSKQGADDVVD
K
NMVGP!ALGGVVGR
NGTVAPSAGSAP!KPLAGTPPAGGGPAVRPEAVR

5

72.0211

4
3

29.0391
31.9898

LRPTPPVTAPARPAGPP!PAAAVDR

3

31.9898

VIGANLK!GAYFLATEVAR

3

72.0211

LLQTASVDQG!SK
QGPVGK!PGPQGKAGPQGK

6
4

42.0106

DTEIP!TEGLR

4

178.0477+
31.9898

SVA!AR
MAPPPAPVRAAPPPPHVAPPRPP!APPR

3
3

42.0106
31.9898

FGRP!LLGATVK
VAHTAEDLALAISTAGNEAKAAFGDASVYLEK!
NVFIHGCDPKADSTR!LILGGK

6
4
3

42.0106
226.0776
541.061

P!GIAGKPGPDGKPGPIGPQGK
SGDVIAEIETDK!ATMEVEAADEGTLAK
GS!LRSTYDGR
GPKGEAGAAGAP!GPAGPAGPAGPAGPAGPKGDA
GPAGPAGPAGPAGPSGATGPAGPK
PAAPPPSPAGPP!AR

5
7
4
4

15.9949
188.033
-2.0156
15.9949

9

31.9898

EVPEA!IRKATESAK
GLP!PAPGVAARPGIPSVAQPQPPGRPALGPGGPA
AAR
ALK!AAGYK

3
5

42.0106
31.9898

3

72.0211

PSAPPTAAPAERPAAPPPAAAPVRPPAP!PAGEAPQ
R
PPAPPAGEAPQRRGPP!PGAVPPNAVPPNAAAPDA
AK
PGIAGKPGP!DGKPGPIGPQGK
PAAPPPSP!AGPPAR

3

31.9898

4

31.9898

4
3

15.9949
31.9898

AYRDILPESSPSELLIAVAGDYNY!VLPTLLVADR
GQ!FAAAKVEPK
GLPPAPGVAARP!GIPSVAQPQPPGRPALGPGGPA
AAR
LMMRK!K

3
6
3

-94.0419
14.0157
31.9898

3

72.0211

P!EPKPAPGPLR

3

31.9898

AEPAMPRP!PR

4

31.9898
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N6,N6,N6-trimethyl-Llysine_
dehydroalanine_
N-acetyl-L-methionine_
N6-biotinyl-L-lysine_
S-methyl-L-cysteine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-biotinyl-L-lysine_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-carboxy-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-methionine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-methionine_
N6,N6,N6-trimethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-1-carboxyethyl-Llysine_
N6-biotinyl-L-lysine_
N-acetyl-L-methionine_

GGAWTFDELNK!FLASPKGYIPGTAMSFAGVPND
K
AYRDILPESSPSELLIAVAGDY!NYVLPTLLVADR
MRAATVNRVDLYM!R
EDNQLSDYLLGTLPELVPGDVKARYPNDK!
DETQIHTHMC!YSEFNDIIDAIAAMDADVISIETSR
PSAP!PTAAPAERPAAPPPAAAPVRPPAPPAGEAPQ
R
APESAAPAAATPKP!AAPPPSPAGPPARR

3

43.0548

3
3
4
3
4

-94.0419
42.0106
226.0776
14.0157
31.9898

5

31.9898

PSAPP!TAAPAERPAAPPPAAAPVRPPAPPAGEAPQ
R
SQSPRIVNIASTEALGATATHSPYSAAK!AGVTGLT
R
APESAAPAAATPKPAAPPPSPAGPP!ARR

4

31.9898

3

72.0211

3

31.9898

GLPP!APGVAARPGIPSVAQPQPPGRPALGPGGPA
AAR
LFGDKVAAK!ELAK
TLALHGAQVVLVNLK!HESGEAAARAITNAGGDA
R
GLPPAP!GVAARPGIPSVAQPQPPGRPALGPGGPA
AAR
NVIDGRAMIASFLTLTIGNNQGMGDVEYAK!
TSVVVLDLAREQPFVP!GGSVASGLAMVEPNPK

5

31.9898

3
7

226.0776
72.0211

4

31.9898

3
3

43.9898
31.9898

GPPPGAPGTPPNATAP!GMTPPPGEAPRR

4

31.9898

ARGTIVNTASISGLFGDYGFAAYNAAK!GAVINLT
R
HVADLVEAAQQFDQPLIATDGADNRSSAAAAAS
K!
PPP!AAPRIQR

7

72.0211

3

226.0776

3

31.9898

PEAP!AAEPNKGEAGAAPK

4

31.9898

M!RALTLVADR
AEPAMPRPP!R

3
3

42.0106
31.9898

TEPPQEASSDQGGLHSVSM!ESKMSGDEVSKALIK
LLQTASVDQGSKVAK!

3
3

42.0106
43.0548

PAPPTVSRPVPP!PMHVAPRVAPPPPPQHAAPR

3

31.9898

APESAAP!AAATPKPAAPPPSPAGPPARR

3

31.9898

EKPAQP!EAAKPEAAK

4

31.9898

PPAPPAGEAPQRRGPPP!GAVPPNAVPPNAAAPDA
AK
VALVTGASKGIGVEIALKLAAEGAAVAVNYASSK
!
AHALGLAALGAK!

3

31.9898

3

72.0211

4

72.0211

VHVLAEAVEK!AK
NIAESLDKMAAGM!LPVIDTEVPLDDVGAALKR

4
3

226.0776
42.0106
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N-acetyl-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
3-(3'-L-histidyl)-Ltyrosine_
trans-2,3-cis-3,4-dihydroxyL-proline_
3-hydroxy-L-proline_
L-3-oxoalanine_
trans-2,3-cis-3,4-dihydroxyL-proline_
S-(L-isoglutamyl)-Lcysteine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-carboxy-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-carboxy-L-lysine_
S-(L-isoglutamyl)-Lcysteine_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-lipoyl-L-lysine_
N6-methyl-L-lysine_
N6-1-carboxyethyl-Llysine_
N-acetyl-L-alanine_
N6-1-carboxyethyl-Llysine_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-1-carboxyethyl-Llysine_

VTIAHPHGNFGAKIP!NLLSAVCGEGVFFSPGIPLIR
LQDIR
AKEAP!PPGPRPAPAPPK

3

42.0106

3

31.9898

FMEGFGVH!TFRLVNADGESTFVK

3

-2.0156

PEPPLQPLP!RTEPPMPRVEAPIMR

3

31.9898

GPKGEAGAAGAPGPAGPAGPAGP!AGPAGPKGDA
GPAGPAGPAGPAGPSGATGPAGPK
RDFLGLAMGAVAAGTSS!TVLGPTTAAAQAQPGG
GSLPRK
SRQDAPSEP!KQR

3

15.9949

3

-2.0156

3

31.9898

ALTLCAGLALGLASAQ!AADKAFQRNELADAAIK

5

-17.0265

PGIPSVAQPQPPGRPALGPGGP!AAARNGTVAPSA
GSAPK
IGQLNPLK!

3

31.9898

4

72.0211

EGLSVVMLMPMIVGLANFHLIAK!
RP!ADPFASLVPEPIAR

6
3

43.9898
31.9898

PK!AGFGNFIQTAAHFAAESSTGTNVEVSTTDDFT
RGVDALVYEVDEANSLMK
LLTTQSLQ!VK

8

43.9898

3

-17.0265

AERDGTVKK!
QPPGERRGP!PPGAPGTPPNATAPGMTPPPGEAPR

3
5

226.0776
31.9898

GP!PPGAVPPNAVPPNAAAPDAAKPDAAK

3

31.9898

10

42.0106

3

31.9898

EDNQLSDYLLGTLPELVPGDVK!ARYPNDK
APESAAPAAATP!KPAAPPPSPAGPPARR

3
4

226.0776
31.9898

APESAAPAAATPKPAAPPP!SPAGPPARR

3

31.9898

QPPGERRGPP!PGAPGTPPNATAPGMTPPPGEAPR

5

31.9898

VK!SGDVIAEIETDKATMEVEAADEGTLAK
VGRKLFVK!
VNVVAPGGARTPIWK!

3
5
3

188.033
14.0157
72.0211

EVPEA!IR
RLSPQGIERAFAINHLGPFLLTNLLLDLIK!

3
3

42.0106
72.0211

LGIPVVPGSDGGVGPDDDAMAIAKEIGFPVLVK!
AAPSAPPPPP!AAAPPHVAPPPPPPAPPR

3
3

226.0776
31.9898

TNLTAVFFTVQAALPYLNDGASIILNGSVISVLGNP
GFAAYAASK!
K!IR

7

72.0211

4

72.0211

P!KAGFGNFIQTAAHFAAESSTGTNVEVSTTDDFT
RGVDALVYEVDEANSLMK
LTTPEPGQWEADTAAELPEPELPPLP!TRPLR
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dehydroalanine_
N-acetyl-L-methionine_
L-3-oxoalanine_
N6-lipoyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
dehydroalanine_
N5-methyl-L-glutamine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-methionine_
omega-N-(ADP-ribosyl)-Larginine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-carboxy-L-lysine_
N-acetyl-L-proline_
N5-methyl-L-glutamine_
N-acetyl-L-methionine_
N-acetyl-L-methionine_
trans-2,3-cis-3,4-dihydroxyL-proline_
L-3-oxoalanine_
N-acetyl-L-methionine_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
3-hydroxy-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6,N6,N6-trimethyl-Llysine_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-methyl-L-alanine_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-lipoyl-L-lysine_

IASIY!HGYPSK
ARVARM!QQMGPEK
DFLGLAMGAVAAGTSSTVLGPTTAAAQAQPGGG
S!LPR
SGDVIAEIETDK!ATMEVEAADEGTLGK
VAPPP!PPQHAAPRMAPPPAPVRAAPPPPHVAPPR

3
3
3

-94.0419
42.0106
-2.0156

4
3

188.033
31.9898

FDY!ATPLTR
SGVIAQ!K
PEPP!VLR

4
4
4

-94.0419
14.0157
31.9898

FLGEGAAWNHVAM!EQAIADSGLEESEISNIR
SLTVTQAELSGRTTIEAAPQSAQADVYRQLAR!

4
3

42.0106
541.061

PEP!PVLR

3

31.9898

IGFPLMLK!STAGGGGIGMQLCHDEATLRER
AAPPPRPQGP!AK

4
3

226.0776
31.9898

QLDIVRREGLSVVMLMPMIVGLANFHLIAK!
LFDGP!STTIKDLWR
VSEDALLPVGAEIQADHFVVGQ!FVDVTGTSTGK
GFAGGMK
AAGGRAVANTADISTM!AGGQSVFDDAIKHFGR
LQPGETVLVFGVGGGVSLAAM!QIAAAAGARVLA
TSRSADK
PALGPGGPAAARNGTVAPSAGSAPKP!LAGTPPAG
GGPAVR
RDFLGLAMGAVAAGTSSTVLGPTTAAAQAQPGG
GS!LPRK
ALGADAVIDAPADKIPAAVM!DLTSGR
TLQGKVALVTGASKGIGVEIALK!

7
6
3

43.9898
42.0106
14.0157

4
3

42.0106
42.0106

4

31.9898

5

-2.0156

3
4

42.0106
72.0211

GPP!PGAVPPNAVPPNAAAPDAAKPDAAK

3

31.9898

GPKGEAGAAGAPGPAGPAGPAGPAGP!AGPKGDA
GPAGPAGPAGPAGPSGATGPAGPK
GEAGAAP!KQGAGK

5

15.9949

3

31.9898

VNGVAPGPVDTAMAK!QVHTADIRSDYR

3

72.0211

GYPIEQLAEK!

4

43.0548

ARGGGAIVNIGSRSSVNAYGGGAAYCASK!

3

72.0211

P!EAPAAEPNKGEAGAAPK

3

31.9898

KNIASGIAHVNSSFNNTTITITDAQGNA!IAWSSAG
TMGFK
LFGDK!VAAKELAK
GLPPAPGVAARPGIPSVAQP!QPPGRPALGPGGPA
AAR
NAVKNHAALATMANAPGK!

3

14.0157

7
3

226.0776
31.9898

5

72.0211

AAAPAAAPAPAAPAPAAAPAAK!APPSDAPLAPSV
RR

4

188.033
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S-methyl-L-cysteine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-biotinyl-L-lysine_
N-acetyl-L-proline_
O4'-(phospho-5'adenosine)-L-tyrosine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-carboxy-L-lysine_
N,N-dimethyl-L-proline_
O-phospho-L-threonine_
N6-biotinyl-L-lysine_
N6-1-carboxyethyl-Llysine_
dehydroalanine_
3-hydroxy-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
S-methyl-L-cysteine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-acetyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
3-hydroxy-L-proline_
N-acetyl-L-methionine_
3-hydroxy-L-proline_
N-acetyl-L-proline_
3'-(1'-L-histidyl)-Ltyrosine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-carboxy-L-lysine_

ETLGAEWRQYEDIFPAIDASSIQQVAVEC!R
APESAAPAAATPKP!AAPPPSPAGPPAR

5
4

14.0157
31.9898

PEHLEAFGLK!HR
VEAIAP!IGETRFSVR
NIY!RAALQKLAAR

10
3
4

226.0776
42.0106
329.0525

NGTVAPSAGSAP!K

4

31.9898

PALGPGGPAAARNGTVAPSAGSAP!KPLAGTPPAG
GGPAVR
PLLGATVK!PKLGLSGR
ADKNMVGP!ALGGVVGRK
SSAQRVIAAT!NSWLHAETRR
NLAALTAAPSTLGDLEFAAAVAAILRGEDEAAK!
IVNIASIAGK!

4

31.9898

4
3
3
3
3

43.9898
29.0391
79.9663
226.0776
72.0211

IASIYHGY!PSK
GPKGEAGAAGAPGPAGPAGPAGPAGPAGP!KGDA
GPAGPAGPAGPAGPSGATGPAGPK
PPAPPAGEAPQRRGP!PPGAVPPNAVPPNAAAPDA
AK
NDMVQYFGEQLSGFAFTKEGWVQSYGSRC!VR
AAPVEAEPP!AEAAAPAPGVEAQPTAAPEPEAKPT
K
PLRPALAEEP!R

9
4

-94.0419
15.9949

3

31.9898

3
3

14.0157
31.9898

4

31.9898

QGADDVVDKITAQGGK!

3

72.0211

PSAPPTAAPAERPAAPPPAAAPVRPP!APPAGEAPQ
R
QPPGERRGPPP!GAPGTPPNATAPGMTPPPGEAPR

4

31.9898

4

31.9898

AIASLIIDGK!
AEP!PIMRADPPILR

3
3

42.0106
31.9898

AAMDATLK!

3

72.0211

PFGLIANNPK!HLGGAIDADAGDK
EKPAQP!EAAK

4
3

226.0776
31.9898

IINNGSISAHAPRPFSAAYTATKHAISGLTK!

3

72.0211

GPKGEAGAAGAPGP!AGPAGPAGPAGPAGPKGDA
GPAGPAGPAGPAGPSGATGPAGPK
DGSGSDAGMAQQVVDAIKAAGGRAVANTADIST
M!AGGQSVFDDAIK
GPKGEAGAAGAPGPAGPAGPAGPAGPAGPKGDA
GP!AGPAGPAGPAGPSGATGPAGPK
MDKFGRP!LLGATVK
Y!VDYPDAFAGWNLVSSIGSYISGFAVLVFLYGMT
LAFIRKER
AAPVEAEP!PAEAAAPAPGVEAQPTAAPEPEAKPT
K
VTIAHPHGNFGAK!

3

15.9949

3

42.0106

5

15.9949

3
3

42.0106
-2.0156

3

31.9898

4

43.9898
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N6-lipoyl-L-lysine_
3-hydroxy-L-proline_
N-acetyl-L-methionine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-lipoyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
L-histidine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6,N6,N6-trimethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6-1-carboxyethyl-Llysine_
N6-1-carboxyethyl-Llysine_
N6-1-carboxyethyl-Llysine_
L-serine_
N6-1-carboxyethyl-Llysine_
3-hydroxy-L-proline_
N6-1-carboxyethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
N-acetyl-L-methionine_
N-acetyl-L-methionine_
N6-biotinyl-L-lysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
3-hydroxy-L-proline_
N-acetyl-L-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_
N6,N6,N6-trimethyl-Llysine_
trans-2,3-cis-3,4-dihydroxyL-proline_
trans-2,3-cis-3,4-dihydroxyL-proline_

SGGGLK!APASAPAGPAIAAAMSDQQIR
PGIAGKP!GPDGKPGPIGPQGK
VGPFAVPKAM!SSTASATLATWFK
P!SAPPTAAPAERPAAPPPAAAPVRPPAPPAGEAPQ
R
GLLK!AAIRDPNPVIFLEHEMLYGQHGEVPK
NGTVAP!SAGSAPK

3
3
3
4

188.033
15.9949
42.0106
31.9898

3
4

188.033
31.9898

GEAGAAPKQGAGKPAAAPAAETPAHTDP!VPAVT
PAPK
AAEP!ATEEPTADTSPAAGK

4

31.9898

5

31.9898

VAAH!PEFDMGAILGHRASADVALLKLAAPLPGK
RGPPPGAP!GTPPNATAPGMTPPPGEAPR

3
3

137.0589
31.9898

P!EPPVLR

3

31.9898

AQK!EDFDYR

3

43.0548

PVPPPMHVAPRVAPPPPPQHAAP!RMAPPPAPVR

3

31.9898

APESAAPAAATPKPAAP!PPSPAGPPARR

5

31.9898

AAVPHMKPGSAIINTASVNSDMPNPMLLAYATTK
!
LAAEGAAVAVNYASSKQGADDVVDKITAQGGK!

3

72.0211

3

72.0211

RMIARQQGGNIVNIASVLGQSVLK!

3

72.0211

GNFCS!GTLIAPDLVLSAAHCVGPGADYK
VINIASIDGIFVNPLETYPYAASK!AGLIHLTR

3
3

87.032
72.0211

GPKGEAGAAGAPGPAGPAGP!AGPAGPAGPKGDA
GPAGPAGPAGPAGPSGATGPAGPK
EGNPNAAHYSASK!

3

15.9949

3

72.0211

VAP!PPPPQHAAPRMAPPPAPVRAAPPPPHVAPPR

3

31.9898

HWIARPAPVNLDISM!PVASAQGDSFPR
PNVSHRLPLSQWAPAM!RLLIDR
LVTTK!
P!PPAAPRIQR

3
4
7
3

42.0106
42.0106
226.0776
31.9898

AP!PPMPERRPADPFASLVPEPIAR

3

31.9898

GEAGEAAP!K
LTELHDVAVANGAGALLINAMP!VGLSAVRMLRK
AEPP!IMRADPPILR

3
3
3

15.9949
42.0106
31.9898

FLTDK!GKADQAVGVTK

4

43.0548

VAPPPPP!QHAAPRMAPPPAPVRAAPPPPHVAPPR

4

31.9898

PAAPPPSPAGP!PAR

9

31.9898
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3'-(1'-L-histidyl)-L-tyrosine
3-(3'-L-histidyl)-L-tyrosine
3-hydroxy-L-proline
3-hydroxy-L-proline
Dehydroalanine
Dehydroalanine
L-3-oxoalanine
L-3-oxoalanine
L-histidine
L-serine
N,N-dimethyl-L-proline
N5-methyl-L-glutamine
N6,N6,N6-trimethyl-L-lysine
N6,N6,N6-trimethyl-L-lysine
N6,N6,N6-trimethyl-L-lysine
N6,N6,N6-trimethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-1-carboxyethyl-L-lysine
N6-acetyl-L-lysine

RPA0832
RPA3310
RPA2801
RPA3593
RPA2627
RPA3893
RPA1365
RPA1990
RPA1895
RPA1895
RPA1535
RPA3250
RPA1535
RPA2394
RPA2907
RPA3693
RPA0109
RPA0234
RPA0532
RPA0586
RPA0895
RPA1110
RPA1684
RPA1757
RPA2073
RPA2160
RPA2172
RPA2186
RPA2417
RPA3074
RPA3191
RPA3287
RPA3339
RPA3474
RPA3551
RPA3552
RPA3631
RPA4306
RPA4464
RPA4618
RPA4786
RPA3764
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N6-biotinyl-L-lysine
N6-biotinyl-L-lysine
N6-biotinyl-L-lysine
N6-biotinyl-L-lysine
N6-biotinyl-L-lysine
N6-biotinyl-L-lysine
N6-carboxy-L-lysine
N6-carboxy-L-lysine
N6-carboxy-L-lysine
N6-carboxy-L-lysine
N6-lipoyl-L-lysine
N6-lipoyl-L-lysine
N6-lipoyl-L-lysine
N6-methyl-L-lysine
N-acetylglycine
N-acetyl-L-alanine
N-acetyl-L-alanine
N-acetyl-L-methionine
N-acetyl-L-methionine
N-acetyl-L-methionine
N-acetyl-L-methionine
N-acetyl-L-methionine
N-acetyl-L-methionine
N-acetyl-L-methionine
N-acetyl-L-methionine
N-acetyl-L-proline
N-acetyl-L-proline
N-acetyl-L-proline
N-acetyl-L-proline
N-methyl-L-alanine
O4'-(phospho-5'-adenosine)-L-tyrosine
O4'-(phospho-5'-uridine)-L-tyrosine
O5-glycosyl-L-hydroxylysine
omega-N-(ADP-ribosyl)-L-arginine
omega-N-(ADP-ribosyl)-L-arginine
O-phospho-L-threonine
S-(L-isoglutamyl)-L-cysteine
S-methyl-L-cysteine
S-methyl-L-cysteine
trans-2,3-cis-3,4-dihydroxy-L-proline
trans-2,3-cis-3,4-dihydroxy-L-proline
trans-2,3-cis-3,4-dihydroxy-L-proline
trans-2,3-cis-3,4-dihydroxy-L-proline

RPA1405
RPA1450
RPA2435
RPA2539
RPA3175
RPA4071
RPA0262
RPA1559
RPA2169
RPA4641
RPA0188
RPA2864
RPA2866
RPA4257
RPA3693
RPA3233
RPA3339
RPA0426
RPA0656
RPA1775
RPA2018
RPA2184
RPA3072
RPA3191
RPA3339
RPA0262
RPA1559
RPA2169
RPA4641
RPA3227
RPA0984
RPA2966
RPA3593
RPA1438
RPA2635
RPA3200
RPA2553
RPA2181
RPA2397
RPA0213
RPA2923
RPA3081
RPA3889
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